https://www.med-life.it/home/image_05/ 2016-02-17T09:02:18+00:00 https://www.med-life.it/?attachment_id=738 2016-02-18T16:21:34+00:00 https://www.med-life.it/home/schermata-2016-07-18-alle-11-06-48/ 2016-07-18T09:07:26+00:00 https://www.med-life.it/chi-siamo/cis/ 2016-07-20T09:18:30+00:00 https://www.med-life.it/raccoglitori/cis-raccoglitori_piccola/ 2016-07-21T12:53:50+00:00 https://www.med-life.it/riviste/the-medical-letter-2/ 2016-07-22T09:37:21+00:00 https://www.med-life.it/riviste/the-medical-letter-3/ 2016-07-22T09:37:36+00:00 https://www.med-life.it/number_articles/tml-n-22016-un-cerotto-a-base-di-sumatriptan-per-lemicrania/tab-1-studi-clinici-su-ionsys/ 2016-08-29T14:17:05+00:00 https://www.med-life.it/number_articles/tml-n-22016-un-cerotto-a-base-di-sumatriptan-per-lemicrania/alcuni-farmaci-a-uso-topico-per-la-colite-ulcerosa-distale/ 2016-08-29T14:24:53+00:00 https://www.med-life.it/?attachment_id=2380 2016-08-30T13:47:03+00:00 https://www.med-life.it/number_articles/tml-n-22016-un-cerotto-a-base-di-sumatriptan-per-lemicrania/pdf/ 2016-09-02T06:57:44+00:00 https://www.med-life.it/number_articles/tml-n-22016-un-cerotto-a-base-di-sumatriptan-per-lemicrania/adobe_pdf_file_icon_32x32/ 2016-09-02T10:09:29+00:00 https://www.med-life.it/number_articles/ad-n-2272015-prescrizione-sicura-nelle-porfirie-acute-autosomiche-dominanti-un-approccio-pratico-parte-ii/ad_227_15_p912_fig1/ 2016-10-07T09:36:22+00:00 https://www.med-life.it/number_articles/ad-n-2272015-prescrizione-sicura-nelle-porfirie-acute-autosomiche-dominanti-un-approccio-pratico-parte-ii/ad_227_15_p913_tab1/ 2016-10-07T09:39:23+00:00 https://www.med-life.it/number_articles/ad-n-2282015-gestione-della-dress-reazione-da-farmaco-con-eosinofilia-e-sintomi-sistemici/ad_228_15_p916_tab1/ 2016-10-07T10:19:31+00:00 https://www.med-life.it/number_articles/ad-n-2282015-gestione-della-dress-reazione-da-farmaco-con-eosinofilia-e-sintomi-sistemici/ad_228_15_p916_tab2/ 2016-10-07T10:20:59+00:00 https://www.med-life.it/number_articles/ad-n-2282015-gestione-della-dress-reazione-da-farmaco-con-eosinofilia-e-sintomi-sistemici/ad_228_15_p917_tab3/ 2016-10-07T10:22:52+00:00 https://www.med-life.it/number_articles/ad-n-2232015-reazioni-da-fotosensibilita-e-tumori-cutanei-associati-a-voriconazolo/ad-223-15-fig1/ 2016-10-07T10:25:20+00:00 https://www.med-life.it/number_articles/ad-n-230-aprile-2016/ad-230-16-tab1/ 2016-10-07T10:30:26+00:00 https://www.med-life.it/number_articles/ad-n-2312016-farmaci-in-grado-di-abbassare-la-soglia-convulsiva/ad-231-16-tab1/ 2016-10-07T10:32:56+00:00 https://www.med-life.it/riviste/the-medical-letter-2016-2/ 2016-10-07T11:05:44+00:00 https://www.med-life.it/number_articles/tml-n-32016-idarucizumab-un-antidoto-per-il-dabigatran/tml-03-16-tab1/ 2016-10-13T07:57:59+00:00 https://www.med-life.it/number_articles/tml-n-32016-bexsero-il-secondo-vaccino-antimeningococcico-di-tipo-b-approvato-dalla-fda/tml-03-16-tab2/ 2016-10-13T08:24:29+00:00 https://www.med-life.it/number_articles/tml-n-32016-cobicistat-e-associazioni-per-lhiv/tml-03-16-tab3/ 2016-10-13T08:25:56+00:00 https://www.med-life.it/number_articles/tml-n-32016-cobicistat-e-associazioni-per-lhiv/tml-03-16-tab4/ 2016-10-13T08:28:53+00:00 https://www.med-life.it/number_articles/tml-n-116-cangrelor-un-farmaco-antiaggregante-ev-per-pci/tml-01-16-tab1/ 2016-10-13T09:01:00+00:00 https://www.med-life.it/number_articles/tml-n-116-cangrelor-un-farmaco-antiaggregante-ev-per-pci/tml-01-16-tab2/ 2016-10-13T09:08:40+00:00 https://www.med-life.it/number_articles/tml-n-12016-farmaci-per-lipotiroidismo/tml-01-16-tab4/ 2016-10-13T09:19:33+00:00 https://www.med-life.it/number_articles/tml-n-12016-farmaci-per-lipotiroidismo/tml-01-16-tab3/ 2016-10-13T09:22:26+00:00 https://www.med-life.it/number_articles/tml-n-22016-un-cerotto-a-base-di-sumatriptan-per-lemicrania/tml-02-16-tab1/ 2016-10-13T10:47:12+00:00 https://www.med-life.it/number_articles/tml-n-22016-due-antipsicotici-iniettabili-a-lunga-durata-dazione-per-la-schizofrenia/tml-02-16-tab2/ 2016-10-13T10:52:46+00:00 https://www.med-life.it/number_articles/tml-n-22016-budesonide-in-schiuma-rettale-per-la-colite-ulcerosa/tml-02-16-tab3/ 2016-10-13T10:59:12+00:00 https://www.med-life.it/number_articles/tml-n-22016-fentanil-transdermico-per-il-dolore-postoperatorio/tml-02-16-tab4/ 2016-10-13T11:01:54+00:00 https://www.med-life.it/number_articles/tml-n-42016-antivirali-per-linfluenza-stagionale-2015-2016/tml-04-16-tab1/ 2016-10-14T07:06:47+00:00 https://www.med-life.it/number_articles/tml-n-42016-diclofenac-per-via-endovenosa/tml-04-16-tab2/ 2016-10-14T07:10:47+00:00 https://www.med-life.it/number_articles/tml-n-42016-empagliflozinmetformina-per-il-diabete-di-tipo-2/tml-04-16-tab3/ 2016-10-14T07:43:13+00:00 https://www.med-life.it/number_articles/tml-n-52016-naloxone-spray-nasale-per-il-sovradosaggio-da-oppioidi/tml-05-16-tab1/ 2016-10-14T09:00:50+00:00 https://www.med-life.it/number_articles/tml-n-52016-naloxone-spray-nasale-per-il-sovradosaggio-da-oppioidi/tml-05-16-tab2/ 2016-10-14T09:01:45+00:00 https://www.med-life.it/number_articles/tml-n-52016-ambrisentan-e-tadalafil-per-lipertensione-arteriosa-polmonare/tml-05-16-tab3/ 2016-10-14T09:04:10+00:00 https://www.med-life.it/number_articles/tml-n-52016-ambrisentan-e-tadalafil-per-lipertensione-arteriosa-polmonare/tml-05-16-tab4/ 2016-10-14T09:06:45+00:00 https://www.med-life.it/number_articles/tml-n-52016-eluxadolina-per-la-sindrome-dellintestino-irritabile-accompagnata-da-diarrea/tml-05-16-tab5/ 2016-10-14T09:17:47+00:00 https://www.med-life.it/number_articles/tml-n-62016-un-vaccino-antinfluenzale-stagionale-adiuvato-per-adulti-in-eta-avanzata/tml-06-16-tab1/ 2016-10-14T10:08:56+00:00 https://www.med-life.it/number_articles/tml-n-62016-elvitegravir-per-lhiv/tml-06-16-tab2/ 2016-10-14T10:10:30+00:00 https://www.med-life.it/number_articles/tml-n-62016-elvitegravir-per-lhiv/tml-06-16-tab3/ 2016-10-14T10:11:36+00:00 https://www.med-life.it/number_articles/tml-n-62016/tml-06-16-tab4/ 2016-10-14T10:12:44+00:00 https://www.med-life.it/number_articles/tml-n-72016-farmaci-per-lacne/tml-07-16-tab1/ 2016-10-14T11:00:46+00:00 https://www.med-life.it/number_articles/tml-n-72016-farmaci-per-lacne/tml-07-16-tab2/ 2016-10-14T11:02:45+00:00 https://www.med-life.it/number_articles/tml-n-72016-farmaci-per-la-rosacea/tml-07-16-tab3/ 2016-10-14T11:04:54+00:00 https://www.med-life.it/number_articles/tml-n-72016-rolapitant-per-la-prevenzione-di-nausea-e-vomito-tardivi-indotti-da-chemioterapia/tml-07-16-tab4/ 2016-10-14T11:09:57+00:00 https://www.med-life.it/number_articles/tml-n-72016-rolapitant-per-la-prevenzione-di-nausea-e-vomito-tardivi-indotti-da-chemioterapia/tml-07-16-tab5/ 2016-10-14T11:10:17+00:00 https://www.med-life.it/number_articles/tml-n-72016-rolapitant-per-la-prevenzione-di-nausea-e-vomito-tardivi-indotti-da-chemioterapia/tml-07-16-tab6/ 2016-10-14T14:02:54+00:00 https://www.med-life.it/number_articles/tml-n-72016/tml-08-16-tab1/ 2016-10-17T10:57:00+00:00 https://www.med-life.it/number_articles/tml-n-72016/tml-08-16-tab2/ 2016-10-17T10:58:14+00:00 https://www.med-life.it/number_articles/tml-n-82016/tml-08-16-tab3/ 2016-10-17T10:59:14+00:00 https://www.med-life.it/number_articles/tml-n-82016/tml-08-16-tab4/ 2016-10-17T11:00:38+00:00 https://www.med-life.it/number_articles/tml-n-82016-patiromer-per-iperpotassiemia/tml-08-16-tab5/ 2016-10-17T11:01:24+00:00 https://www.med-life.it/number_articles/tml-n-92016/tml-09-16-tab1/ 2016-10-17T11:02:44+00:00 https://www.med-life.it/number_articles/tml-n-92016-3/tml-09-16-tab4/ 2016-10-17T11:04:18+00:00 https://www.med-life.it/number_articles/tml-n-92016/tml-09-16-tab2/ 2016-10-17T11:05:19+00:00 https://www.med-life.it/number_articles/tml-n-92016-2/tml-09-16-tab3/ 2016-10-17T11:06:02+00:00 https://www.med-life.it/number_articles/tml-n-132016-cariprazina-per-la-schizofrenia-e-il-disturbo-bipolare-di-tipo-i/tml-13-16-tab1/ 2016-10-20T06:41:47+00:00 https://www.med-life.it/number_articles/tml-n-132016-cariprazina-per-la-schizofrenia-e-il-disturbo-bipolare-di-tipo-i/tml-13-16-tab2/ 2016-10-20T06:42:53+00:00 https://www.med-life.it/number_articles/tml-n-132016-cariprazina-per-la-schizofrenia-e-il-disturbo-bipolare-di-tipo-i/tml-13-16-tab3/ 2016-10-20T06:43:40+00:00 https://www.med-life.it/number_articles/tml-n-132016-cariprazina-per-la-schizofrenia-e-il-disturbo-bipolare-di-tipo-i/tml-13-16-tab4/ 2016-10-20T06:49:05+00:00 https://www.med-life.it/number_articles/tml-n-132016-dispositivo-ricaricabile-maestro-per-la-perdita-di-peso/tml-13-16-tab5-2/ 2016-10-20T06:51:15+00:00 https://www.med-life.it/number_articles/tml-n-182016-repellenti-per-insetti/tml-18-16-tab1/ 2016-10-20T09:09:46+00:00 https://www.med-life.it/number_articles/tml-n-182016-farmaci-per-la-depressione/tml-18-16-tab2/ 2016-10-20T09:22:56+00:00 https://www.med-life.it/number_articles/tml-n-182016-farmaci-per-la-depressione/tml-18-16-tab4/ 2016-10-20T09:33:59+00:00 https://www.med-life.it/number_articles/tml-n-182016-farmaci-per-la-depressione/tml-18-16-tab3/ 2016-10-20T09:35:47+00:00 https://www.med-life.it/number_articles/tml-n-202016-linagliptin-e-metformina-per-il-diabete-di-tipo-2/tml-20-16-tab1/ 2016-10-20T10:52:22+00:00 https://www.med-life.it/number_articles/tml-n-202016-emtricitabinatenofovir-alafenamide-per-lhiv/tml-20-16-tab2/ 2016-10-20T11:15:19+00:00 https://www.med-life.it/number_articles/tml-n-202016-venetoclax-per-la-leucemia-linfatica-cronica/tml-20-16-tab3/ 2016-10-21T06:49:04+00:00 https://www.med-life.it/number_articles/tml-n-212016-farmaci-per-il-disturbo-bipolare/tml-21-16-tab1/ 2016-11-07T11:32:04+00:00 https://www.med-life.it/number_articles/tml-n-212016-farmaci-per-il-disturbo-bipolare/tml-21-16-tab2/ 2016-11-07T11:33:56+00:00 https://www.med-life.it/number_articles/tml-n-212016-sofosbuvirvelpatasvir-per-lepatite-c/tml-21-16-tab3/ 2016-11-07T11:35:20+00:00 https://www.med-life.it/number_articles/tml-n-212016-sofosbuvirvelpatasvir-per-lepatite-c/tml-21-16-tab4/ 2016-11-07T11:37:35+00:00 https://www.med-life.it/number_articles/tml-n-132015-carbidopalevodopa-capsule-a-rilascio-prolungato-rytary/tml-13-15-tab1/ 2016-11-09T08:59:47+00:00 https://www.med-life.it/number_articles/tml-n-132015-carbidopalevodopa-capsule-a-rilascio-prolungato-rytary/tml-13-15-tab2/ 2016-11-09T09:01:32+00:00 https://www.med-life.it/number_articles/tml-n-132015-carbidopalevodopa-capsule-a-rilascio-prolungato-rytary/tml-13-15-tab3/ 2016-11-09T09:02:44+00:00 https://www.med-life.it/number_articles/tml-n-132015-netupitantpalonosetron-akynzeo-per-la-nausea-e-il-vomito-indotti-da-chemioterapia/tml-13-15-tab4/ 2016-11-09T09:03:54+00:00 https://www.med-life.it/number_articles/tml-n-132015-netupitantpalonosetron-akynzeo-per-la-nausea-e-il-vomito-indotti-da-chemioterapia/tml-13-15-tab5/ 2016-11-09T09:05:51+00:00 https://www.med-life.it/number_articles/tml-n-132015-netupitantpalonosetron-akynzeo-per-la-nausea-e-il-vomito-indotti-da-chemioterapia/tml-13-15-tab6/ 2016-11-09T09:07:09+00:00 https://www.med-life.it/number_articles/tml-n-132015-netupitantpalonosetron-akynzeo-per-la-nausea-e-il-vomito-indotti-da-chemioterapia/tml-13-15-tab7/ 2016-11-09T09:16:25+00:00 https://www.med-life.it/number_articles/tml-n-132015-umeclidinio-incruse-ellipta-per-la-bpco/tml-13-15-tab8/ 2016-11-09T09:19:13+00:00 https://www.med-life.it/number_articles/tml-n-132015-umeclidinio-incruse-ellipta-per-la-bpco/tml-13-15-tab9/ 2016-11-09T09:19:58+00:00 https://www.med-life.it/number_articles/tml-n-132015-umeclidinio-incruse-ellipta-per-la-bpco/tml-13-15-tab10/ 2016-11-09T09:20:54+00:00 https://www.med-life.it/number_articles/tml-n-132015-un-nuovo-farmaco-di-associazione-per-il-diabete-di-tipo-2-glyxambi/tml-13-15-tab11/ 2016-11-09T09:22:34+00:00 https://www.med-life.it/number_articles/tml-n-132015-un-nuovo-farmaco-di-associazione-per-il-diabete-di-tipo-2-glyxambi/tml-13-15-tab12/ 2016-11-09T09:24:06+00:00 https://www.med-life.it/number_articles/tml-n-142015-peginterferone-beta-1a-plegridy-per-la-sclerosi-multipla/tml-14-15-tab1/ 2016-11-09T11:06:58+00:00 https://www.med-life.it/number_articles/tml-n-142015-peginterferone-beta-1a-plegridy-per-la-sclerosi-multipla/tml-14-15-tab2/ 2016-11-09T11:08:27+00:00 https://www.med-life.it/number_articles/tml-n-142015-insulina-glargine-concentrata-toujeo-per-il-diabete/tml-14-15-tab3/ 2016-11-09T11:11:09+00:00 https://www.med-life.it/number_articles/tml-n-142015-insulina-glargine-concentrata-toujeo-per-il-diabete/tml-14-15-tab4/ 2016-11-09T11:12:15+00:00 https://www.med-life.it/number_articles/tml-n-142015/tml-14-15-tab5/ 2016-11-09T11:52:59+00:00 https://www.med-life.it/number_articles/tml-n-142015/tml-14-15-tab6/ 2016-11-09T11:58:27+00:00 https://www.med-life.it/number_articles/tml-n-152015-3/tml_15_15_tml_15_15-5/ 2016-11-10T07:41:00+00:00 https://www.med-life.it/number_articles/tml-n-152015-3/tml_15_15_tml_15_15-7/ 2016-11-10T08:00:48+00:00 https://www.med-life.it/number_articles/tml-n-152015-4/tml_15_15_tml_15_15-8/ 2016-11-10T08:25:42+00:00 https://www.med-life.it/chi-siamo/img_6629-2/ 2016-11-10T11:10:44+00:00 https://www.med-life.it/number_articles/tml-n-162015/tml-16-15-tab1/ 2016-11-11T11:52:25+00:00 https://www.med-life.it/number_articles/tml-n-162015-2/tml-16-15-tab2/ 2016-11-11T11:53:31+00:00 https://www.med-life.it/number_articles/tml-n-162015-2/tml-16-15-tab3/ 2016-11-11T11:59:28+00:00 https://www.med-life.it/number_articles/tml-n-162015-3/tml-16-15-tab4/ 2016-11-11T12:01:08+00:00 https://www.med-life.it/numeri-saggio/medical_letter_image/ 2016-11-15T10:42:20+00:00 https://www.med-life.it/numeri-saggio/tml-gratuita/ 2016-11-15T10:52:28+00:00 https://www.med-life.it/home/library-book/ 2016-11-17T16:31:42+00:00 https://www.med-life.it/?attachment_id=3705 2016-11-18T12:37:40+00:00 https://www.med-life.it/?attachment_id=3706 2016-11-18T12:37:54+00:00 https://www.med-life.it/?attachment_id=3707 2016-11-18T12:38:09+00:00 https://www.med-life.it/home/books-at-a-library/ 2016-11-18T14:20:28+00:00 https://www.med-life.it/numeri-saggio/lc_90_15/ 2016-11-23T08:05:02+00:00 https://www.med-life.it/numeri-saggio/lc-90-2015_gratuito/ 2016-11-25T12:30:00+00:00 https://www.med-life.it/numeri-saggio/ad-217-2014_gratuito/ 2016-11-25T12:31:45+00:00 https://www.med-life.it/numeri-saggio/tml-5-2015_gratuito/ 2016-11-25T12:36:33+00:00 https://www.med-life.it/?attachment_id=5110 2016-12-14T09:37:40+00:00 https://www.med-life.it/?attachment_id=5286 2016-12-20T08:57:47+00:00 https://www.med-life.it/buone-feste/cis-buone-feste-2016/ 2016-12-23T12:04:27+00:00 https://www.med-life.it/modalita-di-pagamento/cis-editore-bollettino/ 2017-01-03T15:58:16+00:00 https://www.med-life.it/numeri-saggio/ad_217_14/ 2017-02-20T15:12:35+00:00 https://www.med-life.it/the-medical-letter-nuovi-2017/the-medical-letter-6/ 2017-02-23T12:03:19+00:00 https://www.med-life.it/?attachment_id=13115 2018-04-16T18:45:46+00:00 https://www.med-life.it/?attachment_id=13116 2018-04-16T18:46:52+00:00 https://www.med-life.it/modalita-di-pagamento/paypal_pagasenzaconto_cartadicredito/ 2018-06-22T11:41:37+00:00 https://www.med-life.it/modalita-di-pagamento/paypal_pagasenzaconto_seleziona_cartadicredito/ 2018-06-22T13:32:07+00:00 https://www.med-life.it/modalita-di-pagamento/bollettinomedlife_order2019/ 2019-11-14T14:31:59+00:00 https://www.med-life.it/modalita-di-pagamento/bollettino_stampa-nocausale-2/ 2019-11-14T14:52:06+00:00 https://www.med-life.it/modalita-di-pagamento/tml_12_19-pag_93_tab2/ 2019-11-14T15:54:45+00:00 https://www.med-life.it/modalita-di-pagamento/bollettinoxsito-1/ 2019-11-22T08:54:44+00:00 https://www.med-life.it/buone-feste-2/natale_6/ 2019-12-20T11:19:46+00:00 https://www.med-life.it/number_articles/tml-n-32020-farmaci-antivirali-linfluenza/pag_17_art1_tab1/ 2020-01-24T11:41:18+00:00 https://www.med-life.it/number_articles/tml-n-32020-farmaci-antivirali-linfluenza/pag_17_art1_riepilogo/ 2020-01-24T11:42:03+00:00 https://www.med-life.it/number_articles/tml-n-32020-farmaci-antivirali-linfluenza/pag_18_art1_tab2/ 2020-01-24T11:42:46+00:00 https://www.med-life.it/number_articles/tml-n-32020-farmaci-antivirali-linfluenza/pag_20_art1_biblio1/ 2020-01-24T11:44:22+00:00 https://www.med-life.it/number_articles/tml-n-32020-farmaci-antivirali-linfluenza/pag_20_art1_biblio2/ 2020-01-24T11:44:55+00:00 https://www.med-life.it/number_articles/tml-n-32020-elexacaftortezacaftorivacaftor-la-fibrosi-cistica/pag_21_art2_farmacologia/ 2020-01-24T14:17:28+00:00 https://www.med-life.it/number_articles/tml-n-32020-elexacaftortezacaftorivacaftor-la-fibrosi-cistica/pag_21_art2_riepilogo/ 2020-01-24T14:22:44+00:00 https://www.med-life.it/number_articles/tml-n-32020-elexacaftortezacaftorivacaftor-la-fibrosi-cistica/pag_21_art2_tab1/ 2020-01-24T14:23:45+00:00 https://www.med-life.it/number_articles/tml-n-32020-elexacaftortezacaftorivacaftor-la-fibrosi-cistica/pag_22_art2_tab2/ 2020-01-24T14:24:14+00:00 https://www.med-life.it/number_articles/tml-n-32020-elexacaftortezacaftorivacaftor-la-fibrosi-cistica/pag_23_art2_biblio/ 2020-01-24T14:28:44+00:00 https://www.med-life.it/number_articles/tml-n-32020-corticosteroidi-nella-polmonite-acquisita-comunita/pag_23_art3_riepilogo/ 2020-01-24T14:41:42+00:00 https://www.med-life.it/number_articles/tml-n-32020-corticosteroidi-nella-polmonite-acquisita-comunita/pag_24_art3_biblio1/ 2020-01-24T14:42:14+00:00 https://www.med-life.it/?attachment_id=20043 2020-02-06T11:26:00+00:00 https://www.med-life.it/?attachment_id=20044 2020-02-06T11:29:25+00:00 https://www.med-life.it/?attachment_id=20056 2020-02-07T10:31:29+00:00 https://www.med-life.it/number_articles/ad-n-2532020-vasculite-leucocitoclastica-indotta-dallapixaban/pag_1028_tab1/ 2020-02-24T11:25:24+00:00 https://www.med-life.it/number_articles/ad-n-2532020-vasculite-leucocitoclastica-indotta-dallapixaban/pag_1029_biblio1/ 2020-02-24T11:27:19+00:00 https://www.med-life.it/number_articles/ad-n-2532020-vasculite-leucocitoclastica-indotta-dallapixaban/pag_1030_biblio2/ 2020-02-24T11:27:43+00:00 https://www.med-life.it/number_articles/ad-n-2532020-vasculite-leucocitoclastica-indotta-dallapixaban/pag_1030_biblio3/ 2020-02-24T11:27:59+00:00 https://www.med-life.it/number_articles/tml-n-52020-farmaci-lartrite-psoriasica/pag_33_riepilogo/ 2020-02-25T10:22:42+00:00 https://www.med-life.it/number_articles/tml-n-52020-farmaci-lartrite-psoriasica/pag_36_tab1/ 2020-02-25T10:33:04+00:00 https://www.med-life.it/number_articles/tml-n-52020-farmaci-lartrite-psoriasica/pag_39_biblio1/ 2020-02-25T10:42:38+00:00 https://www.med-life.it/number_articles/tml-n-52020-farmaci-lartrite-psoriasica/pag_39_biblio2/ 2020-02-25T10:43:05+00:00 https://www.med-life.it/number_articles/tml-n-52020-farmaci-lartrite-psoriasica/pag_40_biblio3/ 2020-02-25T10:43:30+00:00 https://www.med-life.it/number_articles/tml-n-52020-farmaci-lartrite-psoriasica/pag_40_biblio4/ 2020-02-25T10:43:54+00:00 https://www.med-life.it/number_articles/tml-n-62020-riduzione-del-rischio-cardiovascolare-icosapent-etile/__pag_41_art1_riepilogo/ 2020-03-17T11:43:32+00:00 https://www.med-life.it/number_articles/tml-n-62020-riduzione-del-rischio-cardiovascolare-icosapent-etile/__pag_42_art1_biblio_1/ 2020-03-17T11:44:11+00:00 https://www.med-life.it/number_articles/tml-n-62020-riduzione-del-rischio-cardiovascolare-icosapent-etile/__pag_43_art1_biblio_2/ 2020-03-17T11:44:37+00:00 https://www.med-life.it/number_articles/tml-n-62020-un-contraccettivo-orale-progestinico/__pag_43_art2_tab_1/ 2020-03-17T11:48:31+00:00 https://www.med-life.it/number_articles/tml-n-62020-un-contraccettivo-orale-progestinico/__pag_43_art2_riepilogo/ 2020-03-17T11:49:25+00:00 https://www.med-life.it/number_articles/tml-n-62020-un-contraccettivo-orale-progestinico/__pag_43_art2_biblio/ 2020-03-17T11:49:57+00:00 https://www.med-life.it/number_articles/tml-n-62020-istradefillina-la-malattia-parkinson/__pag_44_art3_farmacologia/ 2020-03-17T13:01:06+00:00 https://www.med-life.it/number_articles/tml-n-62020-istradefillina-la-malattia-parkinson/__pag_44_art3_riepilogo/ 2020-03-17T13:02:24+00:00 https://www.med-life.it/number_articles/tml-n-62020-istradefillina-la-malattia-parkinson/__pag_44_art3_tab1/ 2020-03-17T13:03:03+00:00 https://www.med-life.it/number_articles/tml-n-62020-istradefillina-la-malattia-parkinson/__pag_45_art3_tab2/ 2020-03-17T13:03:34+00:00 https://www.med-life.it/number_articles/tml-n-62020-istradefillina-la-malattia-parkinson/__pag_46_art3_tab2_segue/ 2020-03-17T13:04:03+00:00 https://www.med-life.it/number_articles/tml-n-62020-istradefillina-la-malattia-parkinson/__pag_46_art3_biblio_1/ 2020-03-17T13:05:32+00:00 https://www.med-life.it/number_articles/tml-n-62020-brolucizumab-la-degenerazione-maculare-legata-alleta/__pag_47_art4_farmacologia/ 2020-03-17T13:28:06+00:00 https://www.med-life.it/number_articles/tml-n-62020-brolucizumab-la-degenerazione-maculare-legata-alleta/__pag_47_art4_riepilogo/ 2020-03-17T13:30:25+00:00 https://www.med-life.it/number_articles/tml-n-62020-brolucizumab-la-degenerazione-maculare-legata-alleta/__pag_48_art4_tab1/ 2020-03-17T13:31:23+00:00 https://www.med-life.it/number_articles/tml-n-62020-brolucizumab-la-degenerazione-maculare-legata-alleta/__pag_48_art4_tab2/ 2020-03-17T13:31:48+00:00 https://www.med-life.it/number_articles/tml-n-62020-brolucizumab-la-degenerazione-maculare-legata-alleta/__pag_48_art4_biblio/ 2020-03-30T08:29:10+00:00 https://www.med-life.it/number_articles/tml-n-72020-farmaci-la-depressione/__pag_49_riepilogo/ 2020-04-01T16:38:36+00:00 https://www.med-life.it/number_articles/tml-n-72020-farmaci-la-depressione/__pag_50_tab1/ 2020-04-01T16:39:36+00:00 https://www.med-life.it/number_articles/tml-n-72020-farmaci-la-depressione/__pag_51_tab1-segue/ 2020-04-01T16:40:16+00:00 https://www.med-life.it/number_articles/tml-n-72020-farmaci-la-depressione/__pag_52_tab2/ 2020-04-01T16:42:01+00:00 https://www.med-life.it/number_articles/tml-n-72020-farmaci-la-depressione/__pag_55_biblio1/ 2020-04-01T16:48:17+00:00 https://www.med-life.it/number_articles/tml-n-72020-farmaci-la-depressione/__pag_55_biblio2/ 2020-04-01T16:48:42+00:00 https://www.med-life.it/number_articles/tml-n-72020-farmaci-la-depressione/__pag_56_biblio3/ 2020-04-01T16:49:08+00:00 https://www.med-life.it/number_articles/tml-n-72020-farmaci-la-depressione/__pag_56_biblio4/ 2020-04-01T16:49:35+00:00 https://www.med-life.it/number_articles/tml-n-82020-polvere-contenente-allergeni-delle-arachidi/__pag_57_art_1_suffisso/ 2020-04-15T15:53:48+00:00 https://www.med-life.it/number_articles/tml-n-82020-polvere-contenente-allergeni-delle-arachidi/__pag_57_art_1_riepilogo/ 2020-04-15T15:54:55+00:00 https://www.med-life.it/number_articles/tml-n-82020-polvere-contenente-allergeni-delle-arachidi/__pag_58_art_1_tab_1/ 2020-04-15T15:56:15+00:00 https://www.med-life.it/number_articles/tml-n-82020-polvere-contenente-allergeni-delle-arachidi/__pag_59_art_1_biblio/ 2020-04-15T16:01:23+00:00 https://www.med-life.it/number_articles/tml-n-82020-lasmiditan-ubrogepant-trattamento-acuto-dellemicrania/__pag_59_art_2_farmacologia/ 2020-04-15T16:06:02+00:00 https://www.med-life.it/number_articles/tml-n-82020-lasmiditan-ubrogepant-trattamento-acuto-dellemicrania/__pag_59_art_2_riepilogo/ 2020-04-15T16:06:32+00:00 https://www.med-life.it/number_articles/tml-n-82020-lasmiditan-ubrogepant-trattamento-acuto-dellemicrania/__pag_60_art_2_tab_1/ 2020-04-15T16:07:47+00:00 https://www.med-life.it/number_articles/tml-n-82020-lasmiditan-ubrogepant-trattamento-acuto-dellemicrania/__pag_61_art_2_tab_2/ 2020-04-15T16:10:23+00:00 https://www.med-life.it/number_articles/tml-n-82020-lasmiditan-ubrogepant-trattamento-acuto-dellemicrania/__pag_62_art_2_riepilogo/ 2020-04-15T16:11:00+00:00 https://www.med-life.it/number_articles/tml-n-82020-lasmiditan-ubrogepant-trattamento-acuto-dellemicrania/__pag_62_art_2_biblio/ 2020-04-15T16:12:59+00:00 https://www.med-life.it/number_articles/tml-n-82020-lasmiditan-ubrogepant-trattamento-acuto-dellemicrania/__pag_63_art_2_biblio2/ 2020-04-15T16:13:39+00:00 https://www.med-life.it/number_articles/tml-n-82020-unassociazione-precostituita-amlodipina-celecoxib/__pag_63_art_3_riepilogo/ 2020-04-15T16:26:35+00:00 https://www.med-life.it/number_articles/tml-n-82020-unassociazione-precostituita-amlodipina-celecoxib/__pag_63_art_3_tab1/ 2020-04-15T16:27:25+00:00 https://www.med-life.it/number_articles/tml-n-82020-unassociazione-precostituita-amlodipina-celecoxib/__pag_63_art_3_biblio/ 2020-04-15T16:29:01+00:00 https://www.med-life.it/number_articles/tml-n-82020-brolucizumab-la-degenerazione-maculare-legata-alleta/__pag_64_addendum_biblio_1/ 2020-04-15T17:04:53+00:00 https://www.med-life.it/number_articles/tml-n-82020-interazioni-farmacologiche-oppioidi-inibitori-orali-del-recettore-piastrinico-p2y/__pag_64_addendum_biblio2/ 2020-04-15T17:08:18+00:00 https://www.med-life.it/number_articles/tml-n-812020-farmaci-la-covid-19/__1_art_1_nota/ 2020-04-20T11:56:35+00:00 https://www.med-life.it/number_articles/tml-n-812020-farmaci-la-covid-19/__2_art_1_biblio/ 2020-04-20T11:57:21+00:00 https://www.med-life.it/number_articles/tml-n-812020-farmaci-la-covid-19/__3_art_1_biblio2/ 2020-04-20T11:57:59+00:00 https://www.med-life.it/number_articles/tml-n-812020-due-farmaci-lanemia-falciforme/__3_art_2_suffisso/ 2020-04-20T12:08:59+00:00 https://www.med-life.it/number_articles/tml-n-812020-due-farmaci-lanemia-falciforme/__3_art_2_farmacologia/ 2020-04-20T12:10:05+00:00 https://www.med-life.it/number_articles/tml-n-812020-due-farmaci-lanemia-falciforme/__3_art_2_riepilogo/ 2020-04-20T12:10:36+00:00 https://www.med-life.it/number_articles/tml-n-812020-due-farmaci-lanemia-falciforme/__4_art_2_tab1/ 2020-04-20T12:12:14+00:00 https://www.med-life.it/number_articles/tml-n-812020-due-farmaci-lanemia-falciforme/__4_art_2_biblio/ 2020-04-20T12:14:26+00:00 https://www.med-life.it/number_articles/tml-n-812020-due-farmaci-lanemia-falciforme/__5_art_2_biblio_2/ 2020-04-20T12:14:59+00:00 https://www.med-life.it/number_articles/tml-n-812020-acido-bempedoico-labbassamento-del-colesterolo-ldl/__5_art_3_farmacologia/ 2020-04-20T12:28:50+00:00 https://www.med-life.it/number_articles/tml-n-812020-acido-bempedoico-labbassamento-del-colesterolo-ldl/__5_art_3_riepilogo/ 2020-04-20T12:29:32+00:00 https://www.med-life.it/number_articles/tml-n-812020-acido-bempedoico-labbassamento-del-colesterolo-ldl/__6_art3_tab_1/ 2020-04-20T12:43:23+00:00 https://www.med-life.it/number_articles/tml-n-812020-acido-bempedoico-labbassamento-del-colesterolo-ldl/__6_art3_tab_2/ 2020-04-20T12:43:47+00:00 https://www.med-life.it/number_articles/tml-n-812020-acido-bempedoico-labbassamento-del-colesterolo-ldl/__7_art3_biblio/ 2020-04-20T12:44:57+00:00 https://www.med-life.it/number_articles/tml-n-812020-cetirizina-via-endovenosa-lorticaria-acuta/__7_art4_farmacologia/ 2020-04-20T12:55:06+00:00 https://www.med-life.it/number_articles/tml-n-812020-cetirizina-via-endovenosa-lorticaria-acuta/__8_art_4_riepilogo/ 2020-04-20T13:29:45+00:00 https://www.med-life.it/number_articles/tml-n-812020-cetirizina-via-endovenosa-lorticaria-acuta/__8_art_4_tab_1/ 2020-04-20T13:30:24+00:00 https://www.med-life.it/number_articles/tml-n-812020-cetirizina-via-endovenosa-lorticaria-acuta/__8_art_4_biblio/ 2020-04-20T13:31:46+00:00 https://www.med-life.it/number_articles/tml-n-92020-farmaci-la-sindrome-dellintestino-irritabile/__pag_65_riepilogo/ 2020-04-27T08:49:34+00:00 https://www.med-life.it/number_articles/tml-n-92020-farmaci-la-sindrome-dellintestino-irritabile/__pag_67_tab1/ 2020-04-27T08:55:24+00:00 https://www.med-life.it/number_articles/tml-n-92020-farmaci-la-sindrome-dellintestino-irritabile/__pag_68_tab2/ 2020-04-27T09:00:23+00:00 https://www.med-life.it/number_articles/tml-n-92020-farmaci-la-sindrome-dellintestino-irritabile/__pag_69_tab2segue/ 2020-04-27T09:01:14+00:00 https://www.med-life.it/number_articles/tml-n-92020-farmaci-la-sindrome-dellintestino-irritabile/__pag_71_biblio/ 2020-04-27T09:10:14+00:00 https://www.med-life.it/number_articles/tml-n-92020-farmaci-la-sindrome-dellintestino-irritabile/__pag_71_biblio_2/ 2020-04-27T09:10:54+00:00 https://www.med-life.it/number_articles/tml-n-92020-farmaci-la-sindrome-dellintestino-irritabile/__pag_72_biblio_3/ 2020-04-27T09:11:28+00:00 https://www.med-life.it/number_articles/tml-n-92020-farmaci-la-sindrome-dellintestino-irritabile/__pag_72_biblio_4/ 2020-04-27T09:11:57+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_89_riepilogo/ 2020-06-17T14:39:46+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_90_tab1/ 2020-06-17T14:41:44+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_90_tab2/ 2020-06-17T14:42:18+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_91_tab3/ 2020-06-17T14:42:56+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_92_tab4/ 2020-06-17T14:43:50+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_93_tab5/ 2020-06-17T14:44:36+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_94_tab6/ 2020-06-17T14:45:29+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_95_tab7/ 2020-06-17T14:46:18+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_96_biblio1/ 2020-06-17T14:46:55+00:00 https://www.med-life.it/number_articles/tml-n-122020-farmaci-lipertensione/__pag_96_biblio2/ 2020-06-17T14:47:30+00:00 https://www.med-life.it/number_articles/tml-n-132020-depressione-respiratoria-gabapentinoidi/tml-13-2020-1599-online_pag_97_inbreve_biblio/ 2020-07-01T14:41:48+00:00 https://www.med-life.it/number_articles/tml-n-132020-soluzione-oftalmica-base-cetirizina-la-congiuntivite-allergica/tml-13-2020-1599-online_pag_98_art1_riepilogo/ 2020-07-01T16:01:57+00:00 https://www.med-life.it/number_articles/tml-n-132020-soluzione-oftalmica-base-cetirizina-la-congiuntivite-allergica/tml-13-2020-1599-online_pag_99_art1_biblio/ 2020-07-01T16:07:16+00:00 https://www.med-life.it/number_articles/tml-n-132020-soluzione-oftalmica-base-cetirizina-la-congiuntivite-allergica/tml-13-2020-1599-online_pag_99_art1_farmacologia/ 2020-07-01T16:11:39+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/tml-13-2020-1599-online_pag_100_art2_riepilogo/ 2020-07-01T16:27:06+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/tml-13-2020-1599-online_pag_100_art2_farmacologia/ 2020-07-01T16:28:01+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/tml-13-2020-1599-online_pag_100_art2_tab1/ 2020-07-01T16:29:05+00:00 https://www.med-life.it/number_articles/tml-n-132020-soluzione-oftalmica-base-cetirizina-la-congiuntivite-allergica/__pag_99_art1_farmacologia/ 2020-07-01T16:39:48+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/__pag_100_art2_riepilogo/ 2020-07-01T16:41:12+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/__pag_100_art2_farmacologia/ 2020-07-01T16:44:21+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/__pag_100_art2_farmacologia-2/ 2020-07-01T16:44:41+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/__pag_100_art2_tab1/ 2020-07-01T16:45:44+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/__pag_101_art2_tab2/ 2020-07-01T16:47:25+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/__pag_101_art2_tab2-2/ 2020-07-01T16:47:38+00:00 https://www.med-life.it/number_articles/tml-n-132020-unassociazione-tre-farmaci-linfezione-helicobacter-pylori/__pag_101_art2_biblio/ 2020-07-01T16:48:39+00:00 https://www.med-life.it/number_articles/tml-n-132020-eptinezumab-la-prevenzione-dellemicrania/__pag_102_art3_suffisso/ 2020-07-01T16:54:34+00:00 https://www.med-life.it/number_articles/tml-n-132020-eptinezumab-la-prevenzione-dellemicrania/__pag_102_art3_farmacologia/ 2020-07-01T16:57:42+00:00 https://www.med-life.it/number_articles/tml-n-132020-eptinezumab-la-prevenzione-dellemicrania/__pag_102_art3_riepilogo/ 2020-07-01T16:58:45+00:00 https://www.med-life.it/number_articles/tml-n-132020-eptinezumab-la-prevenzione-dellemicrania/__pag_102_art_3_tab1/ 2020-07-01T17:03:37+00:00 https://www.med-life.it/number_articles/tml-n-132020-eptinezumab-la-prevenzione-dellemicrania/__pag_103_art3_tab2/ 2020-07-01T17:04:18+00:00 https://www.med-life.it/number_articles/tml-n-132020-eptinezumab-la-prevenzione-dellemicrania/__pag_103_art3_biblio/ 2020-07-01T17:06:36+00:00 https://www.med-life.it/number_articles/tml-n-132020-nuova-associazione-tre-farmaci-diabete-tipo-2/__pag_104_inbreve_tab1/ 2020-07-01T17:14:52+00:00 https://www.med-life.it/number_articles/tml-n-132020-nuova-associazione-tre-farmaci-diabete-tipo-2/_-17/ 2020-07-01T17:15:35+00:00 https://www.med-life.it/number_articles/tml-n-142020-farmaci-la-dermatite-atopica/__pag_105_riepilogo/ 2020-07-09T14:01:30+00:00 https://www.med-life.it/number_articles/tml-n-142020-farmaci-la-dermatite-atopica/__pag_106_tab1/ 2020-07-09T14:34:09+00:00 https://www.med-life.it/number_articles/tml-n-142020-farmaci-la-dermatite-atopica/__pag_109_tab2/ 2020-07-13T09:54:18+00:00 https://www.med-life.it/number_articles/tml-n-142020-farmaci-la-dermatite-atopica/__pag_111_biblio/ 2020-07-13T10:02:23+00:00 https://www.med-life.it/number_articles/tml-n-142020-farmaci-la-dermatite-atopica/__pag_111_biblio2/ 2020-07-13T10:08:57+00:00 https://www.med-life.it/number_articles/tml-n-142020-farmaci-la-dermatite-atopica/__pag_112_biblio3/ 2020-07-13T10:09:35+00:00 https://www.med-life.it/number_articles/tml-n-142020-farmaci-la-dermatite-atopica/__pag_112_biblio4/ 2020-07-13T10:10:06+00:00 https://www.med-life.it/number_articles/tml-n-152020-lemborexant-linsonnia/__pag-113-art-1-farmacologia-01/ 2020-08-03T15:12:16+00:00 https://www.med-life.it/number_articles/tml-n-152020-lemborexant-linsonnia/__pag-113-art-1-riepilogo/ 2020-08-03T15:13:19+00:00 https://www.med-life.it/number_articles/tml-n-152020-lemborexant-linsonnia/__pag-114-art-1-tab1/ 2020-08-03T15:14:13+00:00 https://www.med-life.it/number_articles/tml-n-152020-lemborexant-linsonnia/__pag-115-art-1-tab2/ 2020-08-03T15:14:43+00:00 https://www.med-life.it/number_articles/tml-n-152020-lemborexant-linsonnia/__pag-116-art-1-biblio/ 2020-08-03T15:15:17+00:00 https://www.med-life.it/number_articles/tml-n-152020-meloxicam-ev-dolore/__pag-116-art-2-riepilogo/ 2020-08-03T15:20:47+00:00 https://www.med-life.it/number_articles/tml-n-152020-meloxicam-ev-dolore/__pag-117-art3-tab1/ 2020-08-03T15:21:26+00:00 https://www.med-life.it/number_articles/tml-n-152020-meloxicam-ev-dolore/__pag-118-art3-biblio/ 2020-08-03T15:23:11+00:00 https://www.med-life.it/number_articles/tml-n-152020-dapagliflozin-nuova-indicazione-linsufficienza-cardiaca/__pag-119-art4-tab1/ 2020-08-03T15:34:18+00:00 https://www.med-life.it/number_articles/tml-n-152020-dapagliflozin-nuova-indicazione-linsufficienza-cardiaca/__pag-119-art4-biblio/ 2020-08-03T15:34:54+00:00 https://www.med-life.it/number_articles/tml-n-152020-melatonina-linsonnia-nei-bambini/__pag-119-art5-riepilogo/ 2020-08-03T15:41:30+00:00 https://www.med-life.it/number_articles/tml-n-152020-melatonina-linsonnia-nei-bambini/__pag-120-art5-biblio/ 2020-08-03T15:42:03+00:00 https://www.med-life.it/number_articles/ad-n-2552020-priapismo-indotto-farmaci/pag_1036_tab1/ 2020-08-04T13:23:39+00:00 https://www.med-life.it/number_articles/ad-n-2552020-priapismo-indotto-farmaci/pag_1037_tab2/ 2020-08-04T13:25:00+00:00 https://www.med-life.it/number_articles/ad-n-2552020-priapismo-indotto-farmaci/pag_1038_biblio/ 2020-08-04T13:25:39+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_121_tab_1/ 2020-08-05T12:46:01+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_121_riepilogo/ 2020-08-05T12:46:39+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_122_tab2/ 2020-08-05T12:48:37+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_122_tab3/ 2020-08-05T12:53:34+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_123_tab4/ 2020-08-05T13:02:01+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_125_tab5/ 2020-08-05T13:20:20+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_126_tab6/ 2020-08-05T13:21:24+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_127_biblio_1/ 2020-08-05T13:24:23+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_127_biblio_2/ 2020-08-05T13:24:55+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_128_biblio_3/ 2020-08-05T13:25:30+00:00 https://www.med-life.it/number_articles/tml-n-162020-farmaci-losteoporosi-postmenopausa/__pag_128_biblio_4/ 2020-08-05T13:25:56+00:00 https://www.med-life.it/number_articles/tml-n-172020-lumateperone-la-schizofrenia/__pag_129_art_1_farmacologia/ 2020-08-26T14:16:50+00:00 https://www.med-life.it/number_articles/tml-n-172020-lumateperone-la-schizofrenia/__pag_129_art_1_riepilogo/ 2020-08-26T14:17:38+00:00 https://www.med-life.it/number_articles/tml-n-172020-lumateperone-la-schizofrenia/__pag_130_art_1_tab_1/ 2020-08-26T14:42:59+00:00 https://www.med-life.it/number_articles/tml-n-172020-lumateperone-la-schizofrenia/__pag_130_art_1_tab_2/ 2020-08-26T14:43:51+00:00 https://www.med-life.it/number_articles/tml-n-172020-lumateperone-la-schizofrenia/__pag_131_art_1_tab_3/ 2020-08-26T14:46:02+00:00 https://www.med-life.it/number_articles/tml-n-172020-lumateperone-la-schizofrenia/__pag_132_art_1_biblio/ 2020-08-26T14:49:24+00:00 https://www.med-life.it/number_articles/tml-n-172020-un-impianto-base-bimatoprost-glaucoma/__pag_132_art_2_riepilogo/ 2020-08-26T15:06:23+00:00 https://www.med-life.it/number_articles/tml-n-172020-un-impianto-base-bimatoprost-glaucoma/__pag_133_art_2_tab_1/ 2020-08-26T15:10:25+00:00 https://www.med-life.it/number_articles/tml-n-172020-un-impianto-base-bimatoprost-glaucoma/__pag_133_art_2_biblio/ 2020-08-26T15:18:23+00:00 https://www.med-life.it/number_articles/tml-n-172020-farmaci-scaduti/__pag_134_art_3_biblio/ 2020-08-26T15:35:22+00:00 https://www.med-life.it/number_articles/tml-n-172020-farmaci-scaduti/__pag_135_art_3_biblio2/ 2020-08-26T15:35:58+00:00 https://www.med-life.it/number_articles/tml-n-172020-golodirsen-la-distrofia-muscolare-duchenne/__pag_135_art_4_riepilogo/ 2020-08-26T15:55:59+00:00 https://www.med-life.it/number_articles/tml-n-172020-golodirsen-la-distrofia-muscolare-duchenne/__pag_135_art_4_farmacologia/ 2020-08-26T15:57:20+00:00 https://www.med-life.it/number_articles/tml-n-172020-golodirsen-la-distrofia-muscolare-duchenne/__pag_136_art_4_biblio/ 2020-08-26T16:11:29+00:00 https://www.med-life.it/number_articles/tml-n-182020-artesunato-ev-la-malaria-grave/__pag_137_farmacologia/ 2020-09-08T15:50:40+00:00 https://www.med-life.it/number_articles/ad-n-2562020-farmaci-allattamento/__tab_1/ 2020-09-09T12:47:35+00:00 https://www.med-life.it/number_articles/ad-n-2562020-farmaci-allattamento/__tab_2/ 2020-09-09T12:55:20+00:00 https://www.med-life.it/number_articles/ad-n-2562020-farmaci-allattamento/__biblio_1/ 2020-09-09T12:56:32+00:00 https://www.med-life.it/number_articles/ad-n-2562020-farmaci-allattamento/__biblio_2/ 2020-09-09T12:57:00+00:00 https://www.med-life.it/number_articles/ad-n-2562020-farmaci-allattamento/__biblio_3/ 2020-09-09T12:57:28+00:00 https://www.med-life.it/number_articles/ad-n-2562020-farmaci-allattamento/__biblio_4/ 2020-09-09T12:58:29+00:00 https://www.med-life.it/number_articles/tml-n-182020-artesunato-ev-la-malaria-grave/__pag_137_riepilogo/ 2020-09-09T15:33:47+00:00 https://www.med-life.it/number_articles/tml-n-182020-artesunato-ev-la-malaria-grave/__pag_138_tab_1/ 2020-09-09T15:35:05+00:00 https://www.med-life.it/number_articles/tml-n-182020-artesunato-ev-la-malaria-grave/__pag_139_biblio/ 2020-09-09T16:38:44+00:00 https://www.med-life.it/number_articles/tml-n-182020-artesunato-ev-la-malaria-grave/__pag_140_biblio2/ 2020-09-09T16:39:07+00:00 https://www.med-life.it/number_articles/tml-n-182020-farmaci-sintomi-della-menopausa/__pag_140_art_2_riepilogo/ 2020-09-09T17:07:49+00:00 https://www.med-life.it/number_articles/tml-n-182020-farmaci-sintomi-della-menopausa/__pag_141_art_2_tab_1/ 2020-09-09T17:08:55+00:00 https://www.med-life.it/number_articles/tml-n-182020-farmaci-sintomi-della-menopausa/__pag_142_art_2_tab_2/ 2020-09-09T17:10:48+00:00 https://www.med-life.it/number_articles/tml-n-182020-farmaci-sintomi-della-menopausa/__pag_143_art_2_biblio_1/ 2020-09-09T17:12:09+00:00 https://www.med-life.it/number_articles/tml-n-182020-farmaci-sintomi-della-menopausa/__pag_144_art_2_biblio_2/ 2020-09-09T17:12:41+00:00 https://www.med-life.it/number_articles/tml-n-182020-farmaci-sintomi-della-menopausa/__pag_144_art_2_biblio_3/ 2020-09-09T17:13:08+00:00 https://www.med-life.it/?attachment_id=21303 2020-09-29T09:53:39+00:00 https://www.med-life.it/?attachment_id=21307 2020-09-29T10:26:33+00:00 https://www.med-life.it/?attachment_id=21316 2020-09-29T14:47:21+00:00 https://www.med-life.it/number_articles/tml-n-202020-un-gel-contraccettivo-non-ormonale/__pag_153_art_1_riepilogo/ 2020-10-14T10:08:27+00:00 https://www.med-life.it/number_articles/tml-n-202020-un-gel-contraccettivo-non-ormonale/__pag_154_art_1_tab_1/ 2020-10-14T10:10:07+00:00 https://www.med-life.it/number_articles/tml-n-202020-un-gel-contraccettivo-non-ormonale/__pag_155_art_1_tab_1_segue/ 2020-10-14T10:10:45+00:00 https://www.med-life.it/number_articles/tml-n-202020-un-gel-contraccettivo-non-ormonale/__pag_155_art_1_biblio/ 2020-10-14T10:15:49+00:00 https://www.med-life.it/number_articles/tml-n-202020-ozanimod-la-sclerosi-multipla/__pag_156_art_2_farmacologia/ 2020-10-14T10:24:57+00:00 https://www.med-life.it/number_articles/tml-n-202020-ozanimod-la-sclerosi-multipla/__pag_156_art_2_riepilogo/ 2020-10-14T10:27:28+00:00 https://www.med-life.it/number_articles/tml-n-202020-ozanimod-la-sclerosi-multipla/__pag_157_art_2_tab_1/ 2020-10-14T10:28:05+00:00 https://www.med-life.it/number_articles/tml-n-202020-ozanimod-la-sclerosi-multipla/__pag_157_art_2_tab_2/ 2020-10-14T10:29:21+00:00 https://www.med-life.it/number_articles/tml-n-202020-ozanimod-la-sclerosi-multipla/__pag_158_art_2_biblio/ 2020-10-14T10:30:50+00:00 https://www.med-life.it/number_articles/tml-n-202020-cenobamato-le-crisi-epilettiche-focali/__pag_159_art_3_farmacologia/ 2020-10-14T13:01:20+00:00 https://www.med-life.it/number_articles/tml-n-202020-cenobamato-le-crisi-epilettiche-focali/__pag_159_art_3_riepilogo/ 2020-10-14T13:02:43+00:00 https://www.med-life.it/number_articles/tml-n-202020-cenobamato-le-crisi-epilettiche-focali/__pag_159_art_3_tab_1/ 2020-10-14T13:03:50+00:00 https://www.med-life.it/number_articles/tml-n-202020-cenobamato-le-crisi-epilettiche-focali/__pag_160_art_3_biblio/ 2020-10-14T13:15:13+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_161_riepilogo/ 2020-10-27T13:31:25+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_162_tab_1/ 2020-10-27T13:32:27+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_163_tab_2/ 2020-10-27T13:44:35+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_164_tab_3/ 2020-10-27T13:48:03+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_165_tab_4/ 2020-10-27T13:52:04+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_165_tab_5/ 2020-10-27T14:01:46+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_167_biblio_1/ 2020-10-27T14:07:01+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_167_biblio_2/ 2020-10-27T14:07:44+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_168_biblio_3/ 2020-10-27T14:08:17+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_168_biblio_3-2/ 2020-10-27T14:14:02+00:00 https://www.med-life.it/number_articles/tml-n-212020-farmaci-la-bpco/__pag_168_biblio_4/ 2020-10-27T14:14:31+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_169_riepilogo/ 2020-11-10T23:46:25+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_170_tab_1/ 2020-11-10T23:48:05+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_171_tab_2/ 2020-11-10T23:53:22+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_172_tab_2_segue/ 2020-11-10T23:53:54+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_174_tab_3/ 2020-11-11T00:07:48+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_175_biblio_1/ 2020-11-11T00:08:29+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_175_biblio_2/ 2020-11-11T00:09:00+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_176_biblio_3/ 2020-11-11T00:09:46+00:00 https://www.med-life.it/number_articles/tml-n-222020-farmaci-lemicrania/__pag_177_biblio_4/ 2020-11-11T00:10:22+00:00 https://www.med-life.it/number_articles/ad-n-2572020-reazioni-avverse-cinque-scandali-memorabili/__pag_1046_figura_1/ 2020-11-17T15:26:57+00:00 https://www.med-life.it/number_articles/ad-n-2572020-reazioni-avverse-cinque-scandali-memorabili/__pag_1047_figura_2/ 2020-11-17T15:31:04+00:00 https://www.med-life.it/number_articles/ad-n-2572020-reazioni-avverse-cinque-scandali-memorabili/__pag_1048_biblio_1/ 2020-11-17T15:34:42+00:00 https://www.med-life.it/number_articles/ad-n-2572020-reazioni-avverse-cinque-scandali-memorabili/__pag_1048_biblio_2/ 2020-11-17T15:35:46+00:00 https://www.med-life.it/number_articles/tml-n-232020-tempistiche-somministrazione-del-remdesivir-nella-covid-19/__pag_178_art_1_biblio/ 2020-12-01T15:53:55+00:00 https://www.med-life.it/number_articles/tml-n-232020-nuova-insulina-lispro-diabete/__pag_178_art_2_riepilogo/ 2020-12-01T15:59:44+00:00 https://www.med-life.it/number_articles/tml-n-232020-nuova-insulina-lispro-diabete/__pag_178_art_2_suffisso/ 2020-12-01T16:40:09+00:00 https://www.med-life.it/number_articles/tml-n-232020-nuova-insulina-lispro-diabete/__pag_179_art_2_tab_1/ 2020-12-01T16:41:58+00:00 https://www.med-life.it/number_articles/tml-n-232020-nuova-insulina-lispro-diabete/__pag_179_art_2_biblio_1/ 2020-12-01T16:43:47+00:00 https://www.med-life.it/number_articles/tml-n-232020-nuova-insulina-lispro-diabete/__pag_179_art_2_biblio_2/ 2020-12-01T16:44:26+00:00 https://www.med-life.it/number_articles/tml-n-232020-caplacizumab-littp/__pag_179_art_3_suffisso/ 2020-12-01T16:51:14+00:00 https://www.med-life.it/number_articles/tml-n-232020-caplacizumab-littp/__pag_179_art_3_farmacologia/ 2020-12-01T16:52:29+00:00 https://www.med-life.it/number_articles/tml-n-232020-caplacizumab-littp/__pag_180_art_3_riepilogo/ 2020-12-01T16:55:37+00:00 https://www.med-life.it/number_articles/tml-n-232020-caplacizumab-littp/__pag_180_art_3_tab1/ 2020-12-01T16:59:26+00:00 https://www.med-life.it/number_articles/tml-n-232020-caplacizumab-littp/__pag_180_art_3_biblio_1/ 2020-12-01T17:00:13+00:00 https://www.med-life.it/number_articles/tml-n-232020-apomorfina-via-sublinguale-la-malattia-parkinson/__pag_181_art_4_tab1/ 2020-12-01T17:34:27+00:00 https://www.med-life.it/number_articles/tml-n-232020-apomorfina-via-sublinguale-la-malattia-parkinson/__pag_181_art_4_tab2/ 2020-12-01T17:36:19+00:00 https://www.med-life.it/number_articles/tml-n-232020-apomorfina-via-sublinguale-la-malattia-parkinson/__pag_182_art_4_tab3/ 2020-12-01T17:41:19+00:00 https://www.med-life.it/number_articles/tml-n-232020-apomorfina-via-sublinguale-la-malattia-parkinson/__pag_182_art_4_biblio_1/ 2020-12-01T17:45:37+00:00 https://www.med-life.it/number_articles/tml-n-232020-apomorfina-via-sublinguale-la-malattia-parkinson/__pag_182_art_4_riepilogo/ 2020-12-01T17:53:21+00:00 https://www.med-life.it/number_articles/tml-n-232020-viltolarsen-la-distrofia-muscolare-duchenne/__pag_183_art_5_biblio/ 2020-12-01T17:59:39+00:00 https://www.med-life.it/number_articles/tml-n-232020-due-nuovi-dosaggi-dulaglutide-diabete/__pag_184_art_6_tab1/ 2020-12-01T18:08:51+00:00 https://www.med-life.it/number_articles/tml-n-232020-due-nuovi-dosaggi-dulaglutide-diabete/__pag_184_art_6_biblio_1/ 2020-12-01T18:10:34+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-antivirali-linfluenza-stagionale-2020-2021/__pag_185_art_1_riepilogo/ 2020-12-15T16:11:38+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-antivirali-linfluenza-stagionale-2020-2021/__pag_186_art_1_tab_1/ 2020-12-15T16:12:50+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-antivirali-linfluenza-stagionale-2020-2021/__pag_187_art_1_tab_2/ 2020-12-15T16:20:41+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-antivirali-linfluenza-stagionale-2020-2021/__pag_189_art_1_biblio_1/ 2020-12-15T16:28:28+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-antivirali-linfluenza-stagionale-2020-2021/__pag_189_art_1_biblio_2/ 2020-12-15T16:29:07+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-antivirali-linfluenza-stagionale-2020-2021/__pag_190_art_1_biblio_3/ 2020-12-15T16:29:44+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-concentrato-salbutamolo-privo-conservanti-20-ml/__pag_190_art_2_riepilogo/ 2020-12-15T16:49:09+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-concentrato-salbutamolo-privo-conservanti-20-ml/__pag_191_art_2_biblio/ 2020-12-15T16:51:05+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-nuove-avvertenze-sulle-benzodiazepine/__pag_191_in_breve_biblio/ 2020-12-15T17:05:30+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-nuove-avvertenze-sulluso-dei-fans-gravidanza/__pag_192_in_breve_2/ 2020-12-15T17:11:06+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-budesonide-rilascio-prolungato-la-malattia-crohn/__pag_192_in_breve_tab_1/ 2020-12-15T17:18:24+00:00 https://www.med-life.it/number_articles/tml-n-24-2020-budesonide-rilascio-prolungato-la-malattia-crohn/__pag_192_in_breve_biblio/ 2020-12-15T17:19:00+00:00 https://www.med-life.it/number_articles/ad-n-2582020-bifosfonati-rischio-fratture-atipiche-revisione-narrativa/__pag_1051_tab_1/ 2020-12-29T16:11:47+00:00 https://www.med-life.it/number_articles/ad-n-2582020-bifosfonati-rischio-fratture-atipiche-revisione-narrativa/__pag_1051_tab2/ 2020-12-29T16:13:44+00:00 https://www.med-life.it/number_articles/ad-n-2582020-bifosfonati-rischio-fratture-atipiche-revisione-narrativa/__pag_1052_biblio_1/ 2020-12-29T16:17:17+00:00 https://www.med-life.it/number_articles/ad-n-2582020-bifosfonati-rischio-fratture-atipiche-revisione-narrativa/__pag_1052_biblio_2/ 2020-12-29T16:18:06+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-idroclorotiazide-cancro-della-cute/__pag_01_in_breve_biblio/ 2020-12-30T15:13:41+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-empagliflozin-linsufficienza-cardiaca/__pag_01_art_01_tab_1/ 2020-12-30T15:20:51+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-empagliflozin-linsufficienza-cardiaca/__pag_02_art_01_tab_2/ 2020-12-30T15:21:56+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-empagliflozin-linsufficienza-cardiaca/__pag_03_art_01_biblio/ 2020-12-30T15:22:36+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-minociclina-schiuma-la-rosacea/__pag_03_art_02_riepilogo/ 2020-12-30T15:29:19+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-minociclina-schiuma-la-rosacea/__pag_03_art_02_tab_1/ 2020-12-30T15:32:28+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-minociclina-schiuma-la-rosacea/__pag_04_art_02_tab_2/ 2020-12-30T15:34:39+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-minociclina-schiuma-la-rosacea/__pag_04_art_02_biblio/ 2020-12-30T15:36:34+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-reimmissione-commercio-unassociazione-precostituita-uso-analgesico/__pag_05_art_3_riepilogo/ 2020-12-30T15:44:02+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-reimmissione-commercio-unassociazione-precostituita-uso-analgesico/__pag_05_art_3_biblio/ 2020-12-30T15:45:46+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-due-farmaci-tumore-al-seno-avanzato-her2-positivo/__pag_06_art_4_suffisso/ 2020-12-30T15:52:14+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-due-farmaci-tumore-al-seno-avanzato-her2-positivo/__pag_06_art_4_riepilogo/ 2020-12-30T15:53:30+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-due-farmaci-tumore-al-seno-avanzato-her2-positivo/__pag_06_art_4_farmacologia/ 2020-12-30T15:54:48+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-due-farmaci-tumore-al-seno-avanzato-her2-positivo/__pag_07_art_4_riepilogo/ 2020-12-30T15:56:54+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-due-farmaci-tumore-al-seno-avanzato-her2-positivo/__pag_07_art_4_farmacologia/ 2020-12-30T15:58:47+00:00 https://www.med-life.it/number_articles/tml-n-1-2021-due-farmaci-tumore-al-seno-avanzato-her2-positivo/__pag_07_art_4_biblio/ 2020-12-30T16:00:15+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-procedura-eua-bamlanivimab-un-anticorpo-monoclonale-la-covid-19/__pag_10_art_1_tab-1/ 2021-01-18T16:28:14+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-procedura-eua-bamlanivimab-un-anticorpo-monoclonale-la-covid-19/__pag_10_biblio/ 2021-01-18T16:29:57+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-remdesivir-la-covid-19/__pag_11_art_2_farmacologia/ 2021-01-18T16:41:23+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-remdesivir-la-covid-19/__pag_12_art_2_biblio/ 2021-01-18T16:41:59+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-farmaci-lacne/__pag_12_art_3_riepilogo/ 2021-01-18T17:00:55+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-farmaci-lacne/__pag_13_art_3_tab-1/ 2021-01-18T17:01:57+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-farmaci-lacne/__pag_14_art3_tab-2/ 2021-01-18T17:03:57+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-farmaci-lacne/__pag_15_art3_biblio/ 2021-01-18T17:08:29+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-nuove-raccomandazioni-la-vaccinazione-meningococco-sierogruppo-b/__pag_15_inbreve_tab1/ 2021-01-18T17:28:31+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-nuove-raccomandazioni-la-vaccinazione-meningococco-sierogruppo-b/__pag_15_inbreve_tab2/ 2021-01-18T17:30:09+00:00 https://www.med-life.it/number_articles/tml-n-2-2021-nuove-raccomandazioni-la-vaccinazione-meningococco-sierogruppo-b/__pag_16_inbreve_biblio/ 2021-01-18T17:31:28+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-vaccino-pfizer-biontech-la-covid-19/__pag_18_art1-tab1/ 2021-01-29T15:17:16+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-vaccino-pfizer-biontech-la-covid-19/__pag_18_art-1-biblio/ 2021-01-29T15:18:39+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-baloxavir-la-profilassi-post-esposizione-dellinfluenza/__pag_19_art2_tab1/ 2021-01-29T15:26:45+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-baloxavir-la-profilassi-post-esposizione-dellinfluenza/__pag_19_art2_tab2/ 2021-01-29T15:27:21+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-baloxavir-la-profilassi-post-esposizione-dellinfluenza/__pag_19_art2_biblio/ 2021-01-29T15:29:15+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-opicapone-un-inibitore-della-comt-la-malattia-parkinson/__pag_19_art3_riepilogo/ 2021-01-29T15:35:11+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-opicapone-un-inibitore-della-comt-la-malattia-parkinson/__pag_20_art_3_farmacologia/ 2021-01-29T15:36:01+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-opicapone-un-inibitore-della-comt-la-malattia-parkinson/__pag_20_art_3_tab_1/ 2021-01-29T15:38:02+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-opicapone-un-inibitore-della-comt-la-malattia-parkinson/__pag_21_art3_tab2/ 2021-01-29T15:39:08+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-opicapone-un-inibitore-della-comt-la-malattia-parkinson/__pag_22_art3_biblio/ 2021-01-29T15:41:44+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-metoclopramide-spray-nasale-la-gastroparesi-diabetica/__pag_23_art5_riepilogo/ 2021-01-29T15:58:26+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-metoclopramide-spray-nasale-la-gastroparesi-diabetica/__pag_23_art5_tab2/ 2021-01-29T15:59:23+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-metoclopramide-spray-nasale-la-gastroparesi-diabetica/__pag_23_art5_riepilogo-2/ 2021-01-29T16:02:19+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-metoclopramide-spray-nasale-la-gastroparesi-diabetica/__pag_22_art4_farmacologia/ 2021-01-29T16:04:24+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-metoclopramide-spray-nasale-la-gastroparesi-diabetica/__pag_24_art5_biblio_1/ 2021-01-29T16:08:05+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-metoclopramide-spray-nasale-la-gastroparesi-diabetica/__pag_24_art5_biblio_2/ 2021-01-29T16:08:37+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-asenapina-cerotto-la-schizofrenia/__pag_24_inbreve_tab1/ 2021-01-29T16:41:47+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-asenapina-cerotto-la-schizofrenia/__pag_24_inbreve_tab2/ 2021-01-29T16:42:21+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-asenapina-cerotto-la-schizofrenia/__pag_24_inbreve_biblio/ 2021-01-29T16:46:20+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-vaccino-moderna-la-covid-19/__pag_25_art6_tab1/ 2021-01-30T13:05:34+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-vaccino-moderna-la-covid-19/__pag_25_art6_biblio/ 2021-01-30T13:06:34+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-vaccino-moderna-la-covid-19/__pag_25_art6_biblio2/ 2021-01-30T13:07:05+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-farmaci-antibatterici-la-polmonite-extraospedaliera/__pag_26_art7_tab1/ 2021-01-30T13:14:12+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-farmaci-antibatterici-la-polmonite-extraospedaliera/__pag_27_art7_tab2/ 2021-01-30T13:15:11+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-farmaci-antibatterici-la-polmonite-extraospedaliera/__pag_28_art7_tab3/ 2021-01-30T13:17:01+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-farmaci-antibatterici-la-polmonite-extraospedaliera/__pag_29_art7_tab4/ 2021-01-30T13:18:32+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-farmaci-antibatterici-la-polmonite-extraospedaliera/__pag_29_art7_biblio/ 2021-01-30T13:20:22+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-farmaci-antibatterici-la-polmonite-extraospedaliera/__pag_30_art7_biblio2/ 2021-01-30T13:20:54+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-farmaci-antibatterici-la-polmonite-extraospedaliera/__pag_30_art7_biblio3/ 2021-01-30T13:21:24+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-nuova-insulina-glargine-diabete/__pag_30_inbreve_tab1/ 2021-01-30T13:34:59+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-nuova-insulina-glargine-diabete/__pag_30_inbreve_biblio/ 2021-01-30T13:36:48+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-encorafenib-cancro-metastatico-del-colon-retto/__pag_31_farmacologia/ 2021-01-30T13:43:45+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-encorafenib-cancro-metastatico-del-colon-retto/__pag_31_riepilogo/ 2021-01-30T13:45:29+00:00 https://www.med-life.it/number_articles/tml-n-3-2021-encorafenib-cancro-metastatico-del-colon-retto/__pag_32_biblio/ 2021-01-30T13:46:16+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-farmaci-lasma/__pag_34_art_1_riepilogo/ 2021-02-12T11:28:59+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-farmaci-lasma/__pag_34_art_1_tab1/ 2021-02-12T11:30:40+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-farmaci-lasma/__pag_35_art_1_tab2/ 2021-02-12T11:31:41+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-farmaci-lasma/__pag_36_art_1_tab3/ 2021-02-12T11:33:15+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-farmaci-lasma/__pag_37_art_1_tab4/ 2021-02-12T11:33:53+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-farmaci-lasma/__pag_40_art_1_biblio/ 2021-02-12T14:40:48+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-farmaci-lasma/__pag_41_art_1_biblio2/ 2021-02-12T14:41:39+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-casirivimab-imdevimab-la-covid-19/__pag_41_art_2_tab1/ 2021-02-12T15:39:04+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-casirivimab-imdevimab-la-covid-19/__pag_42_art_2_biblio/ 2021-02-12T15:41:34+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-baricitinib-la-covid-19/__pag_43_art3_tab1/ 2021-02-12T15:54:37+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-baricitinib-la-covid-19/__pag_43_art3_biblio/ 2021-02-12T16:02:52+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-ofatumumab-la-sclerosi-multipla/__pag_44_art_4_farmacologia/ 2021-02-12T16:12:28+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-ofatumumab-la-sclerosi-multipla/__pag_44_art_4_riepilogo/ 2021-02-12T16:13:59+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-ofatumumab-la-sclerosi-multipla/__pag_45_art_4_tab1/ 2021-02-12T16:19:57+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-ofatumumab-la-sclerosi-multipla/__pag_45_art_4_tab2/ 2021-02-12T16:23:34+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-ofatumumab-la-sclerosi-multipla/__pag_45_art_4_biblio/ 2021-02-12T16:24:16+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-amisulpride-ev-la-nausea-vomito-post-operatori/__pag_46_art_5_farmacologia/ 2021-02-12T16:34:38+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-amisulpride-ev-la-nausea-vomito-post-operatori/__pag_46_art_5_tab1/ 2021-02-12T16:35:58+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-amisulpride-ev-la-nausea-vomito-post-operatori/__pag_47_art_5_tab2/ 2021-02-12T16:36:38+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-amisulpride-ev-la-nausea-vomito-post-operatori/__pag_48_art5_riepilogo/ 2021-02-12T16:37:46+00:00 https://www.med-life.it/number_articles/tml-n-4-2021-amisulpride-ev-la-nausea-vomito-post-operatori/__pag_48_art5_biblio/ 2021-02-12T16:38:50+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-un-cerotto-contraccettivo/__pag_49_art_1_riepilogo/ 2021-02-26T11:14:01+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-un-cerotto-contraccettivo/__pag_50_art_1_tab1/ 2021-02-26T11:15:14+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-un-cerotto-contraccettivo/__pag_50_art_1_tab2/ 2021-02-26T11:16:25+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-un-cerotto-contraccettivo/__pag_50_art_1_tab3/ 2021-02-26T11:17:04+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-un-cerotto-contraccettivo/__pag_51_art_1_biblio/ 2021-02-26T11:18:03+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-pitolisant-la-narcolessia/__pag_51_art_2_farmacologia/ 2021-02-26T15:32:25+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-pitolisant-la-narcolessia/__pag_51_art_2_riepilogo/ 2021-02-26T15:33:03+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-pitolisant-la-narcolessia/__pag_51_art_2_tab1/ 2021-02-26T15:35:02+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-pitolisant-la-narcolessia/__pag_52_art_2_tab2/ 2021-02-26T15:37:51+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-pitolisant-la-narcolessia/__pag_53_art_2_biblio/ 2021-02-26T15:49:28+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-pitolisant-la-narcolessia/__pag_53_art_2_biblio2/ 2021-02-26T15:50:06+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-osilodrostat-la-malattia-cushing/__pag_54_art3_farmacologia/ 2021-02-26T16:08:13+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-osilodrostat-la-malattia-cushing/__pag_54_art3_riepilogo/ 2021-02-26T16:10:19+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-osilodrostat-la-malattia-cushing/__pag_55_art_3_tab1/ 2021-02-26T16:12:48+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-osilodrostat-la-malattia-cushing/__pag_55_art_3_biblio/ 2021-02-26T16:14:18+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-avapritinib-gist/__pag_56_art_4_riepilogo/ 2021-02-26T17:03:52+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-avapritinib-gist/__pag_56_art_4_biblio/ 2021-02-26T17:04:39+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-farmaci-la-malattia-parkinson/__pag_57_art5_riepilogo/ 2021-02-26T17:28:10+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-farmaci-la-malattia-parkinson/__pag_58_art_5_tab1/ 2021-02-26T17:32:56+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-farmaci-la-malattia-parkinson/__pag_59_art_5_tab1segue/ 2021-02-26T17:33:38+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-farmaci-la-malattia-parkinson/__pag_63_art_5_biblio_1/ 2021-02-26T17:41:36+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-farmaci-la-malattia-parkinson/__pag_63_art_5_biblio_2/ 2021-02-26T17:43:24+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-farmaci-la-malattia-parkinson/__pag_64_art_5_biblio_3/ 2021-02-26T17:44:01+00:00 https://www.med-life.it/number_articles/tml-n-5-2021-farmaci-la-malattia-parkinson/__pag_64_art_5_biblio_4/ 2021-02-26T17:44:36+00:00 https://www.med-life.it/numeri-saggio/tml_01-19-online-2-pdf/ 2021-03-15T09:48:09+00:00 https://www.med-life.it/lixisenatide-per-il-diabete-di-tipo-2/www-fda-gov/ 2021-03-15T09:48:16+00:00 https://www.med-life.it/interazioni-farmacologiche-clopidogrel-e-ppi/www-fda1-gov/ 2021-03-15T09:48:17+00:00 https://www.med-life.it/gestione-peso-pazienti-obesi/type0product_id755/ 2021-03-15T09:49:48+00:00 https://www.med-life.it/ciclosilicato-sodio-zirconio/www-ema-europa-eu/ 2021-03-15T09:49:53+00:00 https://www.med-life.it/coronavirus/outbreak-novel-coronavirus-disease-2019-covid-19-situation-italy/ 2021-03-15T09:49:58+00:00 https://www.med-life.it/linee-guida-del-nice-covid-19/ng163/ 2021-03-15T09:50:03+00:00 https://www.med-life.it/privacy-e-cookie-policy/attachment/11199649/ 2021-03-15T09:50:29+00:00 https://www.med-life.it/privacy-e-cookie-policy/iubenda-js/ 2021-03-15T09:50:29+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-preparazione-la-colonscopia-compresse-base-sodio-solfato/__pag_65_art_1_riepilogo/ 2021-03-19T10:49:09+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-preparazione-la-colonscopia-compresse-base-sodio-solfato/__pag_66_art_1_tab_1/ 2021-03-19T10:51:34+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-preparazione-la-colonscopia-compresse-base-sodio-solfato/__pag_66_art_1_tab_2/ 2021-03-19T10:52:19+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-preparazione-la-colonscopia-compresse-base-sodio-solfato/__pag_67_art_1_tab_3/ 2021-03-19T10:53:08+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-preparazione-la-colonscopia-compresse-base-sodio-solfato/__pag_68_art_1_biblio/ 2021-03-19T10:55:21+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-vericiguat-linsufficienza-cardiaca/__pag_68_art_3_riepilogo/ 2021-03-19T13:56:21+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-vericiguat-linsufficienza-cardiaca/__pag_68_art_3_farmacologia/ 2021-03-19T13:57:43+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-vericiguat-linsufficienza-cardiaca/__pag_69_art_3_tab1/ 2021-03-19T14:21:07+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-vericiguat-linsufficienza-cardiaca/__pag_69_art_3_biblio/ 2021-03-19T14:24:14+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-un-oppioide-dolore-grave/__pag_69_art_4_riepilogo/ 2021-03-19T14:50:59+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-un-oppioide-dolore-grave/__pag_70_art_4_farmacologia/ 2021-03-19T14:51:37+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-un-oppioide-dolore-grave/__pag_70_art_4_tab_1/ 2021-03-19T14:53:00+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-un-oppioide-dolore-grave/__pag_71_art_4_biblio/ 2021-03-19T14:54:37+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-integratori-base-ashwagandha/__pag_72_art_5_biblio/ 2021-03-19T15:10:58+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-vaccino-johnson-johnson-la-covid-19/__pag_72_art_5_tab_1/ 2021-03-19T15:36:37+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-vaccino-johnson-johnson-la-covid-19/__pag_73_art_5_tab_online/ 2021-03-19T15:37:47+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-vaccino-johnson-johnson-la-covid-19/__pag_73_art_5_biblio/ 2021-03-19T15:38:18+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-vaccino-johnson-johnson-la-covid-19/__pag_73_art_5_biblio-2/ 2021-03-19T15:38:46+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-farmaci-la-sclerosi-multipla/__pag_74_art6_riepilogo/ 2021-03-19T15:49:49+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-farmaci-la-sclerosi-multipla/__pag_77_art6_tab1/ 2021-03-19T16:17:09+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-farmaci-la-sclerosi-multipla/__pag_78_art6_tab1_segue/ 2021-03-19T16:17:45+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-farmaci-la-sclerosi-multipla/__pag_78_art6_biblio_1/ 2021-03-19T16:18:28+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-farmaci-la-sclerosi-multipla/__pag_79_art6_biblio_2/ 2021-03-19T16:18:55+00:00 https://www.med-life.it/number_articles/tml-n-6-2021-farmaci-la-sclerosi-multipla/__pag_79_art6_biblio_3/ 2021-03-19T16:19:23+00:00 https://www.med-life.it/trattamenti-e-vaccini-in-corso-di-studio-per-la-covid-19/covid-19_2021-03/ 2021-03-22T11:04:54+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-bamlanivimab-ed-etesevimab-la-covid-19/__pag_82_art_1_tab_1/ 2021-04-03T13:56:49+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-bamlanivimab-ed-etesevimab-la-covid-19/__pag_82_art_1_biblio/ 2021-04-03T13:59:01+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-oriahnn-sanguinamento-mestruale-anomalo-associato-fibroma/__pag_83_art_2_farmacologia/ 2021-04-03T14:05:31+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-oriahnn-sanguinamento-mestruale-anomalo-associato-fibroma/__pag_83_art2_tab1/ 2021-04-03T14:06:03+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-oriahnn-sanguinamento-mestruale-anomalo-associato-fibroma/__pag_84_art_2_tab2/ 2021-04-03T14:08:36+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-oriahnn-sanguinamento-mestruale-anomalo-associato-fibroma/__pag_84_art_2_riepilogo/ 2021-04-03T14:09:04+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-oriahnn-sanguinamento-mestruale-anomalo-associato-fibroma/__pag_84_art_2_biblio/ 2021-04-03T14:09:30+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-semaglutide-la-perdita-peso/__pag_85_art_3_tab_1/ 2021-04-03T14:16:37+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-semaglutide-la-perdita-peso/__pag_85_art_3_tab_1-copy/ 2021-04-03T14:17:03+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-semaglutide-la-perdita-peso/__pag_85_art_3_biblio/ 2021-04-03T14:18:27+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-colchicina-basso-dosaggio-la-malattia-coronarica/__pag_86_art_4_farmacologia/ 2021-04-03T14:22:46+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-colchicina-basso-dosaggio-la-malattia-coronarica/__pag_86_art_4_riepilogo/ 2021-04-03T14:23:13+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-colchicina-basso-dosaggio-la-malattia-coronarica/__pag_86_art_4_tab_1/ 2021-04-03T14:24:32+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-colchicina-basso-dosaggio-la-malattia-coronarica/__pag_86_art_4_tab_2/ 2021-04-03T14:25:48+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-colchicina-basso-dosaggio-la-malattia-coronarica/__pag_87_art_4_biblio/ 2021-04-03T14:27:24+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-ipertensione-erenumab/__pag_87_inbreve_biblio/ 2021-04-03T14:31:14+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-errata-corrige-vaccino-johnson-johnson-la-covid-19/__pag_88_errata_corrige_bilio/ 2021-04-03T14:35:51+00:00 https://www.med-life.it/number_articles/tml-n-7-2021-errata-corrige-vaccino-johnson-johnson-la-covid-19/__pag_88_errata_corrige_tabella_online/ 2021-04-03T14:36:20+00:00 https://www.med-life.it/number_articles/ad-n-2602021-effetti-avversi-antidoti-comunemente-usati-nei-casi-avvelenamento/pag_1062_biblio-02/ 2021-04-19T10:07:28+00:00 https://www.med-life.it/number_articles/tml-n-8-2021-farmaci-la-rinite-allergica-la-congiuntivite-allergica/__pag_90_tab1-2/ 2021-04-20T14:51:05+00:00 https://www.med-life.it/number_articles/tml-n-8-2021-farmaci-la-rinite-allergica-la-congiuntivite-allergica/__pag_91_tab2/ 2021-04-20T14:52:40+00:00 https://www.med-life.it/number_articles/tml-n-8-2021-farmaci-la-rinite-allergica-la-congiuntivite-allergica/__pag_92_tab3/ 2021-04-20T14:59:10+00:00 https://www.med-life.it/number_articles/tml-n-8-2021-farmaci-la-rinite-allergica-la-congiuntivite-allergica/__pag_94_tab4/ 2021-04-20T15:01:28+00:00 https://www.med-life.it/number_articles/tml-n-8-2021-farmaci-la-rinite-allergica-la-congiuntivite-allergica/__pag_94_riepilogo/ 2021-04-20T15:04:28+00:00 https://www.med-life.it/number_articles/tml-n-8-2021-farmaci-la-rinite-allergica-la-congiuntivite-allergica/__pag_95_biblio_1/ 2021-04-20T15:05:43+00:00 https://www.med-life.it/number_articles/tml-n-8-2021-farmaci-la-rinite-allergica-la-congiuntivite-allergica/__pag_95_biblio_2/ 2021-04-20T15:06:09+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-estensione-dellindicazione-luso-del-sacubitrilvalsartan/__pag_97_in_breve_biblio/ 2021-04-28T13:12:41+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-evinacumab-lipercolesterolemia-familiare-omozigote/__pag_98_art_1_riepilogo/ 2021-04-28T13:20:13+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-evinacumab-lipercolesterolemia-familiare-omozigote/__pag_98_art_1_farmacologia/ 2021-04-28T13:21:55+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-evinacumab-lipercolesterolemia-familiare-omozigote/__pag_99_art_1_tab_1/ 2021-04-28T13:22:35+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-evinacumab-lipercolesterolemia-familiare-omozigote/__pag_99_art_1_biblio/ 2021-04-28T13:23:03+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-vibegron-la-sindrome-della-vescica-iperattiva/__pag_99_art_2_riepilogo/ 2021-04-28T13:31:45+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-vibegron-la-sindrome-della-vescica-iperattiva/__pag_99_art_2_farmacologia/ 2021-04-28T13:32:58+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-vibegron-la-sindrome-della-vescica-iperattiva/__pag_100_art_2_tab_1/ 2021-04-28T13:40:09+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-vibegron-la-sindrome-della-vescica-iperattiva/__pag_100_art_2_biblio/ 2021-04-28T13:41:41+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-vibegron-la-sindrome-della-vescica-iperattiva/__pag_101_art_2_biblio_1/ 2021-04-28T13:42:21+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-fluvoxamina-la-covid-19/__pag_101_art_3_biblio_2/ 2021-04-28T14:31:02+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-tirbanibulin-unguento-1-la-cheratosi-attinica/__pag_102_art_4_riepilogo/ 2021-04-28T14:42:08+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-tirbanibulin-unguento-1-la-cheratosi-attinica/__pag_102_art_4_tab_1/ 2021-04-28T14:44:43+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-tirbanibulin-unguento-1-la-cheratosi-attinica/__pag_103_art_4_tab_2/ 2021-04-28T14:45:56+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-tirbanibulin-unguento-1-la-cheratosi-attinica/__pag_103_art_4_biblio/ 2021-04-28T14:48:14+00:00 https://www.med-life.it/number_articles/tml-n-9-2021-nuove-raccomandazioni-trattamento-dellinfezione-gonococcica/__pag_103_in_breve_2_biblio/ 2021-04-28T15:09:41+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-farmaci-antibatterici-la-malattia-lyme/__pag_106_art_1_tab_1/ 2021-05-24T13:41:15+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-farmaci-antibatterici-la-malattia-lyme/__pag_106_art_1_tab_2/ 2021-05-24T13:42:37+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-farmaci-antibatterici-la-malattia-lyme/__pag_107_art_1_biblio/ 2021-05-24T13:45:08+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-loteprednololo-025-la-sindrome-dellocchio-secco/__pag_107_art_2_tab_1/ 2021-05-24T13:52:00+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-loteprednololo-025-la-sindrome-dellocchio-secco/__pag_108_art_2_riepilogo/ 2021-05-24T13:52:48+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-loteprednololo-025-la-sindrome-dellocchio-secco/__pag_108_art_2_biblio/ 2021-05-24T13:54:38+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-plenity-controllo-del-peso/__pag_109_art_3_riepilogo/ 2021-05-24T14:28:10+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-plenity-controllo-del-peso/__pag_109_art_3_biblio/ 2021-05-24T14:28:46+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-un-vaccino-antimeningococcico-c-w-y/__pag_110_art_4_tab_1/ 2021-05-24T14:38:52+00:00 https://www.med-life.it/number_articles/tml-n-10-2021-un-vaccino-antimeningococcico-c-w-y/__pag_110_art_4_biblio/ 2021-05-24T14:39:24+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-vaccino-pfizerbiontech-la-covid-19-gli-adolescenti-12-15-anni-eta/__pag_111_in_breve_biblio/ 2021-05-31T09:16:44+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-cabotegravirrilpivirina-linfezione-hiv-1/__pag_112_art_1_riepilogo/ 2021-05-31T09:28:28+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-cabotegravirrilpivirina-linfezione-hiv-1/__pag_112_art_1_tab_1/ 2021-05-31T09:31:01+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-cabotegravirrilpivirina-linfezione-hiv-1/__pag_113_art_1_tab_2/ 2021-05-31T09:31:30+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-cabotegravirrilpivirina-linfezione-hiv-1/__pag_113_art_1_biblio/ 2021-05-31T09:33:10+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-tramadolo-soluzione-orale-dolore/__pag_114_art_2_farmacologia/ 2021-05-31T10:31:45+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-tramadolo-soluzione-orale-dolore/__pag_114_art_2_tab_1/ 2021-05-31T10:42:18+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-tramadolo-soluzione-orale-dolore/__pag_114_art_2_biblio_1/ 2021-05-31T10:43:21+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-tramadolo-soluzione-orale-dolore/__pag_114_art_2_biblio_2/ 2021-05-31T10:43:47+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-mannitolo-inalazione-la-fibrosi-cistica/__pag_115_art_3_farmacologia/ 2021-05-31T12:16:49+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-mannitolo-inalazione-la-fibrosi-cistica/__pag_115_art_3_riepilogo/ 2021-05-31T12:17:34+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-mannitolo-inalazione-la-fibrosi-cistica/__pag_115_art_3_tab_1/ 2021-05-31T12:18:36+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-mannitolo-inalazione-la-fibrosi-cistica/__pag_116_art_3_tab2/ 2021-05-31T12:19:09+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-mannitolo-inalazione-la-fibrosi-cistica/__pag_116_art_3_biblio/ 2021-05-31T12:20:43+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-teprotumumab-loftalmopatia-tiroidea/__pag_117_art_4_suffisso/ 2021-05-31T12:30:00+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-teprotumumab-loftalmopatia-tiroidea/__pag_117_art_4_farmacologia/ 2021-05-31T12:33:07+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-teprotumumab-loftalmopatia-tiroidea/__pag_117_art_4_farmacologia-copy/ 2021-05-31T12:34:22+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-teprotumumab-loftalmopatia-tiroidea/__pag_118_art_4_biblio_1/ 2021-05-31T12:36:03+00:00 https://www.med-life.it/number_articles/tml-n-11-2021-teprotumumab-loftalmopatia-tiroidea/__pag_118_art_4_biblio_2/ 2021-05-31T12:36:36+00:00 https://www.med-life.it/number_articles/tml-n-12-2021-farmaci-linsufficienza-cardiaca-cronica/__pag_119_tab_1/ 2021-06-16T13:47:10+00:00 https://www.med-life.it/number_articles/tml-n-12-2021-farmaci-linsufficienza-cardiaca-cronica/__pag_120_tab_2/ 2021-06-16T13:47:49+00:00 https://www.med-life.it/number_articles/tml-n-12-2021-farmaci-linsufficienza-cardiaca-cronica/__pag_121_tab_2-segue/ 2021-06-16T13:48:29+00:00 https://www.med-life.it/number_articles/tml-n-12-2021-farmaci-linsufficienza-cardiaca-cronica/__pag_123_tab_3/ 2021-06-16T14:04:37+00:00 https://www.med-life.it/number_articles/tml-n-12-2021-farmaci-linsufficienza-cardiaca-cronica/__pag_125_riepilogo/ 2021-06-16T14:05:48+00:00 https://www.med-life.it/number_articles/tml-n-12-2021-farmaci-linsufficienza-cardiaca-cronica/__pag_125_biblio_1/ 2021-06-16T14:06:29+00:00 https://www.med-life.it/number_articles/tml-n-12-2021-farmaci-linsufficienza-cardiaca-cronica/__pag_126_biblio_2/ 2021-06-16T14:06:59+00:00 https://www.med-life.it/number_articles/tml-n-12-2021-farmaci-linsufficienza-cardiaca-cronica/__pag_126_biblio_3/ 2021-06-16T14:07:26+00:00 https://www.med-life.it/number_articles/ad-n-2612021-nausea-vomito-indotti-chemioterapia-nei-bambini-assenza-evidenze/__pag_1066-tab-1/ 2021-07-01T14:04:54+00:00 https://www.med-life.it/number_articles/ad-n-2612021-nausea-vomito-indotti-chemioterapia-nei-bambini-assenza-evidenze/__pag_1066-biblio-1/ 2021-07-01T14:06:30+00:00 https://www.med-life.it/number_articles/ad-n-2612021-nausea-vomito-indotti-chemioterapia-nei-bambini-assenza-evidenze/__pag_1066-biblio-2/ 2021-07-01T14:07:12+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-sotrovimab-trattamento-della-covid-19/__pag_128_art_1_tab_1/ 2021-07-05T13:05:22+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-sotrovimab-trattamento-della-covid-19/__pag_128_art_1_biblio/ 2021-07-05T13:06:49+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-viloxazina-rilascio-prolungato-ladhd/__pag_129_art_2_farmacologia/ 2021-07-05T13:14:12+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-viloxazina-rilascio-prolungato-ladhd/__pag_129_art_2_tab_1/ 2021-07-05T13:15:34+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-viloxazina-rilascio-prolungato-ladhd/__pag_130_art_2_tab_2/ 2021-07-05T13:17:54+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-viloxazina-rilascio-prolungato-ladhd/__pag_130_art_2_riepilogo/ 2021-07-05T13:18:22+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-viloxazina-rilascio-prolungato-ladhd/__pag_130_art_2_biblio/ 2021-07-05T13:18:58+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-estetrolodrospirenone-un-contraccettivo-orale-combinato/__pag_131_art3_riepilogo/ 2021-07-05T13:25:53+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-estetrolodrospirenone-un-contraccettivo-orale-combinato/__pag_131_art3_tab_1/ 2021-07-05T13:27:27+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-estetrolodrospirenone-un-contraccettivo-orale-combinato/__pag_132_art_3_tab2/ 2021-07-05T13:27:59+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-estetrolodrospirenone-un-contraccettivo-orale-combinato/__pag_132_art_3_biblio/ 2021-07-05T13:29:14+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-testosterone-orale-lipogonadismo/__pag_133_art_4_tab_1/ 2021-07-05T13:32:59+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-testosterone-orale-lipogonadismo/__pag_133_art_4_riepilogo/ 2021-07-05T13:35:28+00:00 https://www.med-life.it/number_articles/tml-n-13-2021-testosterone-orale-lipogonadismo/__pag_134_art_4_biblio/ 2021-07-05T13:36:20+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-aducanumab-la-malattia-alzheimer/__pag_135_art_1_farmacologia/ 2021-07-12T09:30:50+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-aducanumab-la-malattia-alzheimer/__pag_136_art_1_riepilogo/ 2021-07-12T09:31:33+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-aducanumab-la-malattia-alzheimer/__pag_136_art_1_biblio-1/ 2021-07-12T09:32:58+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-aducanumab-la-malattia-alzheimer/__pag_136_art_1_biblio-2/ 2021-07-12T09:33:37+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-semaglutide-la-perdita-peso/__pag_137_art_2_tab_1/ 2021-07-12T09:39:36+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-semaglutide-la-perdita-peso/__pag_138_art_2_tab_2/ 2021-07-12T09:40:47+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-semaglutide-la-perdita-peso/__pag_138_art_2_biblio_1/ 2021-07-12T09:41:44+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-semaglutide-la-perdita-peso/__pag_138_art_2_biblio_2/ 2021-07-12T09:42:14+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-repellenti-gli-insetti/__pag_139_art_3_riepilogo/ 2021-07-12T10:04:59+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-repellenti-gli-insetti/__pag_140_art_3_tab_1/ 2021-07-12T10:08:53+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-repellenti-gli-insetti/__pag_141_art_3_biblio_1/ 2021-07-12T10:11:14+00:00 https://www.med-life.it/number_articles/tml-n-14-2021-repellenti-gli-insetti/__pag_141_art_3_biblio_2/ 2021-07-12T10:11:45+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-tocilizumab-la-covid-19/__pag_144_art_1_biblio/ 2021-07-22T13:16:45+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-dapagliflozin-linsufficienza-renale-cronica/__pag_145_in_breve_tab_1/ 2021-07-22T13:29:17+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-dapagliflozin-linsufficienza-renale-cronica/__pag_145_in_breve_tab_2/ 2021-07-22T13:30:05+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-dapagliflozin-linsufficienza-renale-cronica/__pag_145_biblio_1/ 2021-07-22T13:31:05+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-creme-solari/__pag_146_art_2_riepilogo/ 2021-07-22T13:35:32+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-creme-solari/__pag_147_art_2_tab_1/ 2021-07-22T13:37:11+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-creme-solari/__pag_148_art_2_tab_2/ 2021-07-22T13:38:44+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-creme-solari/__pag_149_art_2_biblio_1/ 2021-07-22T13:40:28+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-creme-solari/__pag_149_art_2_biblio_2/ 2021-07-22T13:41:03+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-creme-solari/__pag_150_art_2_biblio_3/ 2021-07-22T13:41:32+00:00 https://www.med-life.it/number_articles/tml-n-15-2021-creme-solari/__pag_150_art_2_biblio_4/ 2021-07-22T13:42:05+00:00 https://www.med-life.it/number_articles/ad-n-2622021-la-regola-del-tre/__pag_1070_biblio_1/ 2021-08-13T09:45:35+00:00 https://www.med-life.it/number_articles/ad-n-2622021-la-regola-del-tre/__pag_1070_biblio_2/ 2021-08-13T09:46:12+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-sindrome-guillain-barre-vaccino-johnson-johnson-la-covid-19/__pag_151_in_breve_biblio/ 2021-08-13T10:02:17+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-myfembree-lipermenorrea-associata-ai-fibromi/__pag_152_art_1_farmacologia/ 2021-08-13T10:06:47+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-myfembree-lipermenorrea-associata-ai-fibromi/__pag_152_art_1_tab_1/ 2021-08-13T10:07:22+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-myfembree-lipermenorrea-associata-ai-fibromi/__pag_153_art_1_tab_2/ 2021-08-13T10:08:55+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-myfembree-lipermenorrea-associata-ai-fibromi/__pag_153_art_1_riepilogo-2/ 2021-08-13T10:10:08+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-myfembree-lipermenorrea-associata-ai-fibromi/__pag_153_art_1_biblio/ 2021-08-13T10:10:48+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-ponesimod-la-sclerosi-multipla/__pag_154_art_2_farmacologia/ 2021-08-13T10:37:33+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-ponesimod-la-sclerosi-multipla/__pag_154_art_2_riepilogo/ 2021-08-13T10:39:24+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-ponesimod-la-sclerosi-multipla/__pag_155_art_2_tab_1/ 2021-08-13T10:41:03+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-ponesimod-la-sclerosi-multipla/__pag_155_art_2_biblio/ 2021-08-13T10:42:23+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-fenfluramina-la-sindrome-dravet/__pag_156_art_3_farmacologia/ 2021-08-13T10:46:06+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-fenfluramina-la-sindrome-dravet/__pag_156_art_3_tab_1/ 2021-08-13T10:47:11+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-fenfluramina-la-sindrome-dravet/__pag_157_art_3_tab_2/ 2021-08-13T10:48:34+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-fenfluramina-la-sindrome-dravet/__pag_157_art_3_riepilogo/ 2021-08-13T10:49:47+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-fenfluramina-la-sindrome-dravet/__pag_158_art_3_biblio_1/ 2021-08-13T10:51:04+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-fenfluramina-la-sindrome-dravet/__pag_158_art_3_biblio_2/ 2021-08-13T10:51:34+00:00 https://www.med-life.it/number_articles/tml-n-16-2021-fenfluramina-la-sindrome-dravet/__pag_158_nel_prossimo_numero/ 2021-08-13T10:52:08+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-shingrix-adulti-immunocompromessi/__pag_159_in_breve_tab_1/ 2021-08-30T08:49:55+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-shingrix-adulti-immunocompromessi/__pag_160_in_breve_biblio_1/ 2021-08-30T08:50:26+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-shingrix-adulti-immunocompromessi/__pag_160_in_breve_biblio_2/ 2021-08-30T08:50:30+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-casirivimab-imdevimab-la-profilassi-post-esposizione-alla-covid-19/__pag_160_art_1_tab_1/ 2021-08-30T08:58:34+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-casirivimab-imdevimab-la-profilassi-post-esposizione-alla-covid-19/__pag_160_art_1_tab_2/ 2021-08-30T08:59:16+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-casirivimab-imdevimab-la-profilassi-post-esposizione-alla-covid-19/__pag_161_art_1_biblio/ 2021-08-30T08:59:37+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-finerenone-linsufficienza-renale-cronica/__pag_161_art_2_farmacologia/ 2021-08-30T09:10:35+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-finerenone-linsufficienza-renale-cronica/__pag_162_art_2_tab_1/ 2021-08-30T09:15:04+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-finerenone-linsufficienza-renale-cronica/__pag_162_art_2_riepilogo/ 2021-08-30T09:15:55+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-finerenone-linsufficienza-renale-cronica/__pag_162_art_2_biblio/ 2021-08-30T09:16:21+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-dasiglucagone-lipoglicemia-grave/__pag_163_art_3_farmacologia/ 2021-08-30T09:32:10+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-dasiglucagone-lipoglicemia-grave/__pag_163_art_3_riepilogo/ 2021-08-30T09:32:16+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-dasiglucagone-lipoglicemia-grave/__pag_163_art_3_tab_1/ 2021-08-30T09:33:58+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-dasiglucagone-lipoglicemia-grave/__pag_164_art_3_tab_2/ 2021-08-30T09:34:04+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-dasiglucagone-lipoglicemia-grave/__pag_164_art_3_biblio/ 2021-08-30T09:36:44+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-voclosporina-la-nefrite-lupica/__pag_164_art_4_farmacologia/ 2021-08-30T09:41:10+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-voclosporina-la-nefrite-lupica/__pag_165_art_4_tab_1/ 2021-08-30T09:42:35+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-voclosporina-la-nefrite-lupica/__pag_165_art_4_riepilogo/ 2021-08-30T09:44:01+00:00 https://www.med-life.it/number_articles/tml-n-17-2021-voclosporina-la-nefrite-lupica/__pag_166_art_4_biblio/ 2021-08-30T09:44:50+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-trattamento-dellinfezione-clostridioides-difficile/__pag_168_art_1_raccomandazioni/ 2021-09-17T12:31:43+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-trattamento-dellinfezione-clostridioides-difficile/__pag_169_art_1_tab_1/ 2021-09-17T12:34:16+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-trattamento-dellinfezione-clostridioides-difficile/__pag_170_art_1_biblio_1/ 2021-09-17T12:37:39+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-trattamento-dellinfezione-clostridioides-difficile/__pag_171_art_1_biblio_2/ 2021-09-17T12:38:23+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-ibrexafungerp-la-candidosi-vulvovaginale/__pag_171_art_2_riepilogo/ 2021-09-17T12:51:37+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-ibrexafungerp-la-candidosi-vulvovaginale/__pag_171_art_2_farmacologia/ 2021-09-17T12:52:57+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-ibrexafungerp-la-candidosi-vulvovaginale/__pag_172_art_2_tab_1/ 2021-09-17T12:53:51+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-ibrexafungerp-la-candidosi-vulvovaginale/__pag_172_art_2_tab_2/ 2021-09-17T13:30:56+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-ibrexafungerp-la-candidosi-vulvovaginale/__pag_173_art_2_biblio/ 2021-09-17T14:34:20+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-rilonacept-la-pericardite-ricorrente/__pag_173_art_3_tab_1/ 2021-09-17T14:55:46+00:00 https://www.med-life.it/number_articles/tml-n-18-2021-rilonacept-la-pericardite-ricorrente/__pag_174_art_3_biblio/ 2021-09-17T14:56:17+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-terza-dose-dei-vaccini-base-mrna-la-covid-19-negli-immunocompromessi/__pag_175_in_breve_tab_1/ 2021-09-30T08:34:15+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-terza-dose-dei-vaccini-base-mrna-la-covid-19-negli-immunocompromessi/__pag_176_in_breve_biblio_1/ 2021-09-30T08:35:17+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-terza-dose-dei-vaccini-base-mrna-la-covid-19-negli-immunocompromessi/__pag_176_in_breve_biblio_2/ 2021-09-30T08:35:44+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-anifrolumab-lupus-eritematoso-sistemico/__pag_176_art_1_suffisso/ 2021-09-30T08:42:36+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-anifrolumab-lupus-eritematoso-sistemico/__pag_176_art_1_farmacologia/ 2021-09-30T08:43:30+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-anifrolumab-lupus-eritematoso-sistemico/__pag_177_art_1_tab_1/ 2021-09-30T08:45:45+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-anifrolumab-lupus-eritematoso-sistemico/__pag_177_art_1_riepilogo/ 2021-09-30T08:46:40+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-anifrolumab-lupus-eritematoso-sistemico/__pag_177_art_1_biblio/ 2021-09-30T08:48:05+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-ozanimod-la-colite-ulcerosa/__pag_178_art_2_riepilogo-2/ 2021-09-30T09:15:02+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-ozanimod-la-colite-ulcerosa/__pag_178_art_2_farmacologia/ 2021-09-30T09:16:21+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-ozanimod-la-colite-ulcerosa/__pag_178_art_2_tab_1/ 2021-09-30T09:17:06+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-ozanimod-la-colite-ulcerosa/__pag_178_art_2_tab_2/ 2021-09-30T09:18:06+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-ozanimod-la-colite-ulcerosa/__pag_179_art_2_tab_3/ 2021-09-30T09:18:42+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-ozanimod-la-colite-ulcerosa/__pag_180_art_2_tab_3-segue/ 2021-09-30T09:19:57+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-ozanimod-la-colite-ulcerosa/__pag_181_art_2_biblio/ 2021-09-30T09:21:06+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-nuova-formulazione-del-naloxone-spray-nasale-sovradosaggio-oppioidi/__pag_181_in_breve_tab_1/ 2021-09-30T09:27:33+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-nuova-formulazione-del-naloxone-spray-nasale-sovradosaggio-oppioidi/__pag_182_in_breve_tab_2/ 2021-09-30T09:28:30+00:00 https://www.med-life.it/number_articles/tml-n-19-2021-nuova-formulazione-del-naloxone-spray-nasale-sovradosaggio-oppioidi/__pag_182_in_breve_biblio/ 2021-09-30T09:29:43+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-vaccino-antinfluenzale-2021%ef%9a%ba2022/__pag_183_art_1_tab_1/ 2021-10-14T16:14:45+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-vaccino-antinfluenzale-2021%ef%9a%ba2022/__pag_184_art_1_riepilogo/ 2021-10-14T16:15:42+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-vaccino-antinfluenzale-2021%ef%9a%ba2022/__pag_184_art_1_tab_2/ 2021-10-14T16:18:33+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-vaccino-antinfluenzale-2021%ef%9a%ba2022/__pag_186_art_1_biblio_1/ 2021-10-14T16:20:09+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-vaccino-antinfluenzale-2021%ef%9a%ba2022/__pag_187_art_1_biblio_2/ 2021-10-14T16:20:41+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-unassociazione-serdexmetilfenidato-dexmetilfenidato-ladhd/__pag_187_art_2_farmacologia/ 2021-10-14T16:32:11+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-unassociazione-serdexmetilfenidato-dexmetilfenidato-ladhd/__pag_188_art_2_tab_1/ 2021-10-14T16:33:33+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-unassociazione-serdexmetilfenidato-dexmetilfenidato-ladhd/__pag_188_art_2_riepilogo/ 2021-10-14T16:34:57+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-unassociazione-serdexmetilfenidato-dexmetilfenidato-ladhd/__pag_189_art_2_biblio_1/ 2021-10-14T16:36:35+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-unassociazione-serdexmetilfenidato-dexmetilfenidato-ladhd/__pag_189_art_2_biblio_2/ 2021-10-14T16:37:07+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-insulina-glargine-intercambiabile/__pag_189_in_breve_tab_1/ 2021-10-14T16:45:34+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-insulina-glargine-intercambiabile/__pag_189_in_breve_biblio_1/ 2021-10-14T16:46:20+00:00 https://www.med-life.it/number_articles/tml-n-20-2021-nuove-avvertenze-sugli-inibitori-delle-janus-kinasi/__pag_190_in_breve_2_biblio_1/ 2021-10-14T16:53:14+00:00 https://www.med-life.it/number_articles/ad-n-2632021-prevalenza-caratteristiche-delle-interazioni-farmacologiche-pazienti-ospedalizzati-nellarea-della-capitale-danese/__pag_1073_tab_1/ 2021-10-26T13:56:35+00:00 https://www.med-life.it/number_articles/ad-n-2632021-prevalenza-caratteristiche-delle-interazioni-farmacologiche-pazienti-ospedalizzati-nellarea-della-capitale-danese/__pag_1074_tab_2/ 2021-10-26T13:57:15+00:00 https://www.med-life.it/number_articles/ad-n-2632021-prevalenza-caratteristiche-delle-interazioni-farmacologiche-pazienti-ospedalizzati-nellarea-della-capitale-danese/__pag_1075_biblio/ 2021-10-26T14:00:10+00:00 https://www.med-life.it/number_articles/ad-n-2632021-prevalenza-caratteristiche-delle-interazioni-farmacologiche-pazienti-ospedalizzati-nellarea-della-capitale-danese/__pag_1076_banner/ 2021-10-26T14:01:42+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-dose-richiamo-del-vaccino-pfizerbiontech-comirnaty-la-covid-19/__pag_192_art_1_tab_1/ 2021-10-27T10:41:33+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-dose-richiamo-del-vaccino-pfizerbiontech-comirnaty-la-covid-19/__pag_192_art_1_tab_2/ 2021-10-27T10:43:12+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-dose-richiamo-del-vaccino-pfizerbiontech-comirnaty-la-covid-19/__pag_192_art_1_biblio_1/ 2021-10-27T10:46:32+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-dose-richiamo-del-vaccino-pfizerbiontech-comirnaty-la-covid-19/__pag_193_art_1_biblio_2/ 2021-10-27T10:47:14+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-bamlanivimab-ed-etesevimab-la-profilassi-post-esposizione-alla-covid-19/__pag_193_art_2_tab_1/ 2021-10-27T11:37:25+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-bamlanivimab-ed-etesevimab-la-profilassi-post-esposizione-alla-covid-19/__pag_194_art_2_tab_2/ 2021-10-27T11:38:51+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-bamlanivimab-ed-etesevimab-la-profilassi-post-esposizione-alla-covid-19/__pag_194_art_2_biblio_1/ 2021-10-27T11:39:48+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-bamlanivimab-ed-etesevimab-la-profilassi-post-esposizione-alla-covid-19/__pag_194_art_2_biblio_2/ 2021-10-27T11:40:18+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-trattamento-dellonicomicosi/__pag_195_art_3_riepilogo/ 2021-10-27T11:47:22+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-trattamento-dellonicomicosi/__pag_196_art_3_tab_1/ 2021-10-27T11:48:21+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-trattamento-dellonicomicosi/__pag_197_art_3_biblio_1/ 2021-10-27T11:50:23+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-trattamento-dellonicomicosi/__pag_198_art_3_biblio_2/ 2021-10-27T11:51:05+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-trattamento-dellonicomicosi/__pag_198_art_3_biblio_3/ 2021-10-27T11:51:49+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-trattamento-dellonicomicosi/__pag_198_art_3_prox_numeri/ 2021-10-27T11:52:35+00:00 https://www.med-life.it/number_articles/tml-n-21-2021-trattamento-dellonicomicosi/__pag_198_banner/ 2021-10-27T11:53:04+00:00 https://www.med-life.it/?attachment_id=24296 2021-11-12T09:14:23+00:00 https://www.med-life.it/?attachment_id=24297 2021-11-12T10:06:21+00:00 https://www.med-life.it/?attachment_id=24298 2021-11-12T10:26:49+00:00 https://www.med-life.it/?attachment_id=24302 2021-11-12T14:00:29+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-atogepant-la-prevenzione-dell-emicrania/__pag_200_art_1/ 2021-11-18T10:55:16+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-atogepant-la-prevenzione-dell-emicrania/__pag_200_art_1_farmacologia/ 2021-11-18T10:56:17+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-atogepant-la-prevenzione-dell-emicrania/__pag_200_art_1_tab_1/ 2021-11-18T10:57:06+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-atogepant-la-prevenzione-dell-emicrania/__pag_201_art_1_tab_2/ 2021-11-18T10:57:43+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-empagliflozin-linsufficienza-cardiaca-frazione-eiezione-ridotta/__pag_201_art_2_tab_1/ 2021-11-18T10:58:55+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-rivaroxaban-nuova-indicazione-larteriopatia-periferica/__pag_202_art_3_tab_1/ 2021-11-18T11:01:05+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-trilaciclib-la-prevenzione-della-mielosoppressione-correlata-alla-chemioterapia/__pag_203_art_3_farmacologia/ 2021-11-18T11:02:17+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-trilaciclib-la-prevenzione-della-mielosoppressione-correlata-alla-chemioterapia/__pag_204_art_3_tab_1/ 2021-11-18T11:03:12+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-trilaciclib-la-prevenzione-della-mielosoppressione-correlata-alla-chemioterapia/__pag_204_art_3_punti_chiave/ 2021-11-18T11:03:47+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-apoaequorina-la-memoria/__pag_205_art_3_prossimamente/ 2021-11-18T11:04:43+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-atogepant-la-prevenzione-dell-emicrania/pag_201_art_1_biblio/ 2021-11-18T14:56:14+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-empagliflozin-linsufficienza-cardiaca-frazione-eiezione-ridotta/pag_202_art_2_biblio/ 2021-11-18T14:59:46+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-rivaroxaban-nuova-indicazione-larteriopatia-periferica/pag_202_art_3_biblio_1/ 2021-11-18T15:04:22+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-rivaroxaban-nuova-indicazione-larteriopatia-periferica/pag_202_art_3_biblio_2/ 2021-11-18T15:04:49+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-trilaciclib-la-prevenzione-della-mielosoppressione-correlata-alla-chemioterapia/pag_204_art_4_biblio_1/ 2021-11-18T15:08:06+00:00 https://www.med-life.it/number_articles/tml-n-22-2021-apoaequorina-la-memoria/pag_205_art_5_biblio/ 2021-11-18T15:10:11+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-farmaci-lartrite-reumatoide/__pag_208_art_1_punti_chiave/ 2021-12-01T09:32:28+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-farmaci-lartrite-reumatoide/__pag_208_art_1_tab_1/ 2021-12-01T09:33:26+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-farmaci-lartrite-reumatoide/__pag_210_art_1_tab_2/ 2021-12-01T09:37:32+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-farmaci-lartrite-reumatoide/__pag_213_art_1_biblio_1/ 2021-12-01T09:41:47+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-farmaci-lartrite-reumatoide/__pag_213_art_1_biblio_2/ 2021-12-01T09:42:19+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-farmaci-lartrite-reumatoide/__pag_214_art_1_biblio_3/ 2021-12-01T09:42:57+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-farmaci-lartrite-reumatoide/__pag_214_art_1_biblio_4/ 2021-12-01T09:43:34+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-vaccino-pfizerbiontech-la-covid-19-autorizzato-nei-bambini-5%ef%9a%ba11-anni/__pag_214_inbreve_biblio/ 2021-12-01T16:38:14+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-dosi-richiamo-dei-vaccini-la-covid-19/__pag_215_art_2_tab_1/ 2021-12-01T16:58:18+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-dosi-richiamo-dei-vaccini-la-covid-19/__pag_216_art_2_biblio/ 2021-12-01T17:00:12+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-dosi-richiamo-dei-vaccini-la-covid-19/__pag_217_art_2_biblio_2/ 2021-12-01T17:01:37+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-due-nuovi-vaccini-pneumococcici/__pag_217_art_3_tab_1/ 2021-12-01T17:16:39+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-due-nuovi-vaccini-pneumococcici/__pag_218_art_3_tab_2/ 2021-12-01T17:18:18+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-due-nuovi-vaccini-pneumococcici/__pag_219_art_3_tab_3/ 2021-12-01T17:20:02+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-due-nuovi-vaccini-pneumococcici/__pag_219_art_3_biblio/ 2021-12-01T17:21:37+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-due-nuovi-vaccini-pneumococcici/__pag_219_art_3_biblio_2/ 2021-12-01T17:23:12+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-olanzapinasamidorfano-la-schizofrenia-disturbo-bipolare/__pag_220_art_4_punti_chiave/ 2021-12-01T17:32:44+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-olanzapinasamidorfano-la-schizofrenia-disturbo-bipolare/__pag_220_art_4_tab_1/ 2021-12-01T17:34:21+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-olanzapinasamidorfano-la-schizofrenia-disturbo-bipolare/__pag_220_art_4_tab_2/ 2021-12-01T17:35:16+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-olanzapinasamidorfano-la-schizofrenia-disturbo-bipolare/__pag_221_art_4_biblio/ 2021-12-01T17:37:39+00:00 https://www.med-life.it/number_articles/tml-n-23-2021-olanzapinasamidorfano-la-schizofrenia-disturbo-bipolare/__pag_222_pubblicita/ 2021-12-01T17:38:12+00:00 https://www.med-life.it/number_articles/ad-n-2642021-reazioni-avverse-ai-medicinali-base-erbe/__pag_1080_tab_1/ 2021-12-20T12:38:30+00:00 https://www.med-life.it/number_articles/ad-n-2642021-reazioni-avverse-ai-medicinali-base-erbe/__pag_1081_biblio_1/ 2021-12-20T12:40:06+00:00 https://www.med-life.it/number_articles/ad-n-2642021-reazioni-avverse-ai-medicinali-base-erbe/__pag_1081_biblio_2/ 2021-12-20T12:40:53+00:00 https://www.med-life.it/number_articles/ad-n-2642021-reazioni-avverse-ai-medicinali-base-erbe/__pag_1082_biblio_3/ 2021-12-20T12:41:25+00:00 https://www.med-life.it/number_articles/ad-n-2642021-reazioni-avverse-ai-medicinali-base-erbe/__pag_1082_biblio_4/ 2021-12-20T12:42:04+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-farmaci-disturbo-uso-alcol/__pag_224_art_1_tab_1/ 2021-12-21T13:50:28+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-farmaci-disturbo-uso-alcol/__pag_224_art_1_punti_chiave/ 2021-12-21T14:35:21+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-farmaci-disturbo-uso-alcol/__pag_225_art_1_tab_2/ 2021-12-21T14:37:03+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-farmaci-disturbo-uso-alcol/__pag_227_art_1_biblio_1/ 2021-12-21T14:41:04+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-farmaci-disturbo-uso-alcol/__pag_227_art_1_biblio_2/ 2021-12-21T14:41:51+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-farmaci-disturbo-uso-alcol/__pag_228_art_1_biblio_3/ 2021-12-21T14:42:20+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-vareniclina-spray-nasale-la-malattia-dellocchio-secco/__pag_228_art_2_punti_chiave/ 2021-12-21T14:54:22+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-vareniclina-spray-nasale-la-malattia-dellocchio-secco/__pag_228_art_2_tab_1/ 2021-12-21T14:54:51+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-vareniclina-spray-nasale-la-malattia-dellocchio-secco/__pag_229_art_2_biblio_1/ 2021-12-21T14:56:51+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-clascoterone-crema-lacne/__pag_229_art_3_punti_chiave/ 2021-12-21T15:05:55+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-clascoterone-crema-lacne/__pag_229_art_3_tab_1/ 2021-12-21T15:06:27+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-clascoterone-crema-lacne/__pag_230_art_3_tab_2/ 2021-12-21T15:07:00+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-clascoterone-crema-lacne/__pag_231_art_3_biblio_1/ 2021-12-21T15:09:17+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-clascoterone-crema-lacne/__pag_231_art_3_biblio_2/ 2021-12-21T15:09:50+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-un-spray-nasale-base-diidroergotamina-lemicrania/__pag_231_art_4_punti_chiave/ 2021-12-21T15:14:11+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-un-spray-nasale-base-diidroergotamina-lemicrania/__pag_232_art_4_farmacologia/ 2021-12-21T15:14:49+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-un-spray-nasale-base-diidroergotamina-lemicrania/__pag_233_art_4_biblio_1/ 2021-12-21T15:18:50+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-soluzione-orale-sali-misti-oxibato-lipersonnia-idiopatica/__pag_234_art_5_punti_chiave/ 2021-12-21T15:30:00+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-soluzione-orale-sali-misti-oxibato-lipersonnia-idiopatica/__pag_234_art_5_biblio_1/ 2021-12-21T15:31:22+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-abemaciclib-carcinoma-mammario-fase-iniziale/__pag_235_in_breve_biblio/ 2021-12-21T15:37:57+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-dosi-richiamo-dei-vaccini-mrna-la-covid-19-tutti-gli-adulti/__pag_236_in_breve_2_tab_1/ 2021-12-21T15:41:59+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-dosi-richiamo-dei-vaccini-mrna-la-covid-19-tutti-gli-adulti/__pag_236_in_breve_2_biblio_1/ 2021-12-21T15:42:30+00:00 https://www.med-life.it/number_articles/tml-n-24-2021-dosi-richiamo-dei-vaccini-mrna-la-covid-19-tutti-gli-adulti/__pag_236_in_breve_2_biblio_2/ 2021-12-21T15:42:54+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-tixagevimab-cilgavimab-la-profilassi-pre-esposizione-alla-covid-19/__pag_2_art_1_tab_1/ 2022-01-07T09:55:03+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-tixagevimab-cilgavimab-la-profilassi-pre-esposizione-alla-covid-19/__pag_2_art_1_biblio/ 2022-01-07T09:56:51+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-farmaci-antivirali-linfluenza-2021-2022/__pag_3_art_2_punti_chiave/ 2022-01-07T10:03:36+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-farmaci-antivirali-linfluenza-2021-2022/__pag_3_art_2_tab_1/ 2022-01-07T10:04:51+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-farmaci-antivirali-linfluenza-2021-2022/__pag_4_art_2_tab_2/ 2022-01-07T10:06:13+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-farmaci-antivirali-linfluenza-2021-2022/__pag_6_art_2_biblio_1/ 2022-01-07T10:08:59+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-farmaci-antivirali-linfluenza-2021-2022/__pag_6_art_2_biblio_2/ 2022-01-07T10:09:35+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-farmaci-antivirali-linfluenza-2021-2022/__pag_7_art_2_biblio_3/ 2022-01-07T10:10:14+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-farmaci-antivirali-linfluenza-2021-2022/__pag_7_art_2_biblio_4/ 2022-01-07T10:10:49+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-paliperidone-due-volte-allanno-la-schizofrenia/__pag_7_in_breve_tab_1/ 2022-01-07T10:24:20+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-paliperidone-due-volte-allanno-la-schizofrenia/__pag_8_in_breve_biblio/ 2022-01-07T10:25:18+00:00 https://www.med-life.it/number_articles/tml-n-1-2022-paliperidone-due-volte-allanno-la-schizofrenia/__pag_8_pubblicita/ 2022-01-07T10:26:26+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-paxlovid-trattamento-della-covid-19/__pag_10_art_1_biblio_1/ 2022-01-19T10:14:19+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-paxlovid-trattamento-della-covid-19/__pag_10_art_1_biblio_2/ 2022-01-19T10:14:54+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-molnupiravir-trattamento-della-covid-19/__pag_11_art_2_biblio_1/ 2022-01-19T10:22:25+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-miferistone-posta-linterruzione-della-gravidanza/__pag_11_in_breve_biblio_1/ 2022-01-19T10:28:19+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-ruxolitinib-la-dermatite-atopica/__pag_12_art_3_farmacologia/ 2022-01-19T11:05:17+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-ruxolitinib-la-dermatite-atopica/__pag_13_art_3_punti_chiave/ 2022-01-19T11:06:49+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-ruxolitinib-la-dermatite-atopica/__pag_13_art_3_biblio_1/ 2022-01-19T11:08:15+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-bupivacainameloxicam-dolore-postoperatorio/__pag_14_art_4_tab_1/ 2022-01-19T11:21:24+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-bupivacainameloxicam-dolore-postoperatorio/__pag_14_art_4_punti_chiave/ 2022-01-19T11:23:23+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-bupivacainameloxicam-dolore-postoperatorio/__pag_15_art_4_biblio/ 2022-01-19T11:24:47+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-vaccino-pfizer-biontech-la-covid-19/__pag_15_agg_covid_biblio/ 2022-01-19T11:29:05+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-anticorpi-monoclonali-la-covid-19/__pag_15_anticorpi_biblio/ 2022-01-19T11:35:15+00:00 https://www.med-life.it/number_articles/tml-n-2-2022-anticorpi-monoclonali-la-covid-19/__pag_15_pubblicita/ 2022-01-19T11:36:38+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-pilocarpina-soluzione-oftalmica-la-presbiopia/__pag_17_art_1_punti_chiave/ 2022-02-04T14:51:21+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-pilocarpina-soluzione-oftalmica-la-presbiopia/__pag_18_art_1_farmacologia/ 2022-02-04T14:52:34+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-pilocarpina-soluzione-oftalmica-la-presbiopia/__pag_18_art_1_tab_1/ 2022-02-04T14:53:35+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-pilocarpina-soluzione-oftalmica-la-presbiopia/__pag_18_art_1_biblio/ 2022-02-04T14:56:01+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-difelikefalin-prurito-associato-alla-malattia-renale-cronica/__pag_19_art_2_farmacologia/ 2022-02-04T14:59:54+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-difelikefalin-prurito-associato-alla-malattia-renale-cronica/__pag_19_art_2_punti_chiave/ 2022-02-04T15:01:27+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-difelikefalin-prurito-associato-alla-malattia-renale-cronica/__pag_19_art_2_biblio/ 2022-02-04T15:03:59+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-lonapegsomatropina-deficit-ormone-della-crescita/__pag_20_art_3_farmacologia-2/ 2022-02-04T15:09:12+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-lonapegsomatropina-deficit-ormone-della-crescita/__pag_20_art_3_tab_1-2/ 2022-02-04T15:10:52+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-lonapegsomatropina-deficit-ormone-della-crescita/__pag_21_art_3_tab_2/ 2022-02-04T15:11:52+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-lonapegsomatropina-deficit-ormone-della-crescita/__pag_21_art_3_punti_chiave/ 2022-02-04T15:13:29+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-lonapegsomatropina-deficit-ormone-della-crescita/__pag_22_art_3_biblio/ 2022-02-04T15:14:16+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-farmaci-lotite-media-acuta-nei-bambini/__pag_22_art_4_punti_chiave/ 2022-02-04T15:18:12+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-farmaci-lotite-media-acuta-nei-bambini/__pag_23_art_5_tab_1/ 2022-02-04T15:20:25+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-farmaci-lotite-media-acuta-nei-bambini/__pag_23_art_5_biblio/ 2022-02-04T15:22:28+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-glicopirronio-sintomi-dellulcera-peptica/__pag_24_art_6_biblio/ 2022-02-04T15:28:01+00:00 https://www.med-life.it/number_articles/tml-n-3-2022-glicopirronio-sintomi-dellulcera-peptica/__pag_24_prossimamente/ 2022-02-04T15:29:30+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-tezepelumab-lasma-grave/__pag_26_art_1_tab_1/ 2022-02-17T10:19:33+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-tezepelumab-lasma-grave/__pag_26_art_1_punti_chiave/ 2022-02-17T10:20:29+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-tezepelumab-lasma-grave/__pag_26_art_1_biblio/ 2022-02-17T10:22:07+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-remimazolam-la-sedazione-procedurale-breve/__pag_26_art_2_punti_chiave/ 2022-02-17T10:26:39+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-remimazolam-la-sedazione-procedurale-breve/__pag_27_art_2_tab_1/ 2022-02-17T10:27:28+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-remimazolam-la-sedazione-procedurale-breve/__pag_27_art_2_tab_2/ 2022-02-17T10:29:17+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-remimazolam-la-sedazione-procedurale-breve/__pag_28_art_2_biblio/ 2022-02-17T10:30:30+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-odevixibat-la-colestasi-intraepatica-familiare-progressiva-associata-prurito/__pag_28_art_3_farmacologia/ 2022-02-17T10:35:27+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-odevixibat-la-colestasi-intraepatica-familiare-progressiva-associata-prurito/__pag_28_art_3_punti_chiave/ 2022-02-17T10:36:02+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-odevixibat-la-colestasi-intraepatica-familiare-progressiva-associata-prurito/__pag_29_art_3_biblio/ 2022-02-17T10:37:10+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-cabotegravir-la-profilassi-pre-esposizione-dellhiv-1/__pag_29_art_4_farmacologia/ 2022-02-17T10:41:01+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-cabotegravir-la-profilassi-pre-esposizione-dellhiv-1/__pag_30_art_5_tab_1/ 2022-02-17T10:43:19+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-cabotegravir-la-profilassi-pre-esposizione-dellhiv-1/__pag_30_art_5_punti_chiave/ 2022-02-17T10:43:47+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-cabotegravir-la-profilassi-pre-esposizione-dellhiv-1/__pag_31_art_5_biblio/ 2022-02-17T10:44:59+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-remdesivir-nei-pazienti-ambulatoriali-covid-19-ad-alto-rischio/__pag_31_agg_covid_biblio/ 2022-02-17T10:50:05+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-linee-guida-nih-trattamento-ambulatoriale/__pag_32_art_6_tab_1/ 2022-02-17T10:54:32+00:00 https://www.med-life.it/number_articles/tml-n-4-2022-linee-guida-nih-trattamento-ambulatoriale/__pag_32_art_6_biblio/ 2022-02-17T10:55:05+00:00 https://www.med-life.it/number_articles/ad-n-2652021-cardiotossicita-correlata-al-trattamento-inibitori-dellaromatasi-nel-tumore-del-seno/_biblio_1/ 2022-02-24T14:34:02+00:00 https://www.med-life.it/number_articles/ad-n-2652021-cardiotossicita-correlata-al-trattamento-inibitori-dellaromatasi-nel-tumore-del-seno/_biblio_2/ 2022-02-24T14:37:41+00:00 https://www.med-life.it/number_articles/tml-n-5-2022-farmaci-non-oppioidi-dolore/__pag_34_punti_chiave/ 2022-03-09T13:50:48+00:00 https://www.med-life.it/number_articles/tml-n-5-2022-farmaci-non-oppioidi-dolore/__pag_35_tab_1/ 2022-03-09T13:51:52+00:00 https://www.med-life.it/number_articles/tml-n-5-2022-farmaci-non-oppioidi-dolore/__pag_36_tab_1_segue/ 2022-03-09T13:52:42+00:00 https://www.med-life.it/number_articles/tml-n-5-2022-farmaci-non-oppioidi-dolore/__pag_38_tab_2/ 2022-03-09T13:56:01+00:00 https://www.med-life.it/number_articles/tml-n-5-2022-farmaci-non-oppioidi-dolore/__pag_39_biblio_1/ 2022-03-09T13:58:27+00:00 https://www.med-life.it/number_articles/tml-n-5-2022-farmaci-non-oppioidi-dolore/__pag_39_biblio_2/ 2022-03-09T13:59:03+00:00 https://www.med-life.it/number_articles/tml-n-5-2022-farmaci-non-oppioidi-dolore/__pag_40_biblio_3/ 2022-03-09T13:59:48+00:00 https://www.med-life.it/number_articles/tml-n-5-2022-farmaci-non-oppioidi-dolore/__pag_40_biblio_4/ 2022-03-09T14:00:28+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-bebtelovimab-trattamento-della-covid-19/__pag_41_art_1_tab_1/ 2022-03-21T09:56:03+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-bebtelovimab-trattamento-della-covid-19/__pag_42_art_1_biblio/ 2022-03-21T10:00:49+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-inclisiran-labbassamento-del-colesterolo-ldl/__pag_43_art_2_farmacologia/ 2022-03-21T10:11:56+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-inclisiran-labbassamento-del-colesterolo-ldl/__pag_43_art_2_punti_chiave/ 2022-03-21T10:13:38+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-inclisiran-labbassamento-del-colesterolo-ldl/__pag_43_art_2_tab_1/ 2022-03-21T10:14:43+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-inclisiran-labbassamento-del-colesterolo-ldl/__pag_44_art_2_tab_2/ 2022-03-21T10:15:38+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-inclisiran-labbassamento-del-colesterolo-ldl/__pag_45_art_2_biblio/ 2022-03-21T10:18:16+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-faricimab-la-degenerazione-maculare-senile-ledema-maculare-diabetico/__pag_45_art_3_punti_chiave/ 2022-03-21T10:29:08+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-faricimab-la-degenerazione-maculare-senile-ledema-maculare-diabetico/__pag_45_art_3_tab_1/ 2022-03-21T10:30:57+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-faricimab-la-degenerazione-maculare-senile-ledema-maculare-diabetico/__pag_46_art_3_tab_2/ 2022-03-21T10:32:37+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-faricimab-la-degenerazione-maculare-senile-ledema-maculare-diabetico/__pag_47_art_3_biblio/ 2022-03-21T10:36:03+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-intervallo-le-somministrazioni-della-serie-primaria-dei-vaccini-mrna/__pag_47_agg_covid_biblio/ 2022-03-21T10:42:12+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-vaccinazione-richiamo-nelle-persone-immunocompromesse/__pag_48_agg_covid_biblio2/ 2022-03-21T10:54:04+00:00 https://www.med-life.it/number_articles/tml-n-6-2022-aumento-del-dosaggio-tixagevimabcilgavimab/__pag_48_aum_dosaggio_biblio_1/ 2022-03-21T11:00:41+00:00 https://www.med-life.it/number_articles/tml-n-7-2022-farmaci-la-gerd-lulcera-peptica/__pag_49_punti_chiave/ 2022-04-01T15:52:21+00:00 https://www.med-life.it/number_articles/tml-n-7-2022-farmaci-la-gerd-lulcera-peptica/__pag_50_tab_1/ 2022-04-01T15:53:11+00:00 https://www.med-life.it/number_articles/tml-n-7-2022-farmaci-la-gerd-lulcera-peptica/__pag_51_tab_2/ 2022-04-01T15:53:49+00:00 https://www.med-life.it/number_articles/tml-n-7-2022-farmaci-la-gerd-lulcera-peptica/__pag_54_tab_3/ 2022-04-01T15:56:56+00:00 https://www.med-life.it/number_articles/tml-n-7-2022-farmaci-la-gerd-lulcera-peptica/__pag_55_biblio_1/ 2022-04-01T16:07:25+00:00 https://www.med-life.it/number_articles/tml-n-7-2022-farmaci-la-gerd-lulcera-peptica/__pag_56_biblio_2/ 2022-04-01T16:08:08+00:00 https://www.med-life.it/number_articles/tml-n-7-2022-farmaci-la-gerd-lulcera-peptica/__pag_56_biblio_3/ 2022-04-01T16:08:44+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-nuova-indicazione-empagliflozin-linsufficienza-cardiaca/__pag_58_in_breve_biblio/ 2022-04-14T11:58:37+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-tramadolocelecoxib-dolore/__pag_58_art_1_punti_chiave/ 2022-04-14T12:05:10+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-tramadolocelecoxib-dolore/__pag_59_art_1_biblio-2/ 2022-04-14T12:07:00+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-tramadolocelecoxib-dolore/__pag_60_art_1_biblio_1/ 2022-04-14T12:07:58+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-lente-contatto-rilascia-un-farmaco-la-congiuntivite-allergica/__pag_60_art_2_punti_chiave/ 2022-04-14T12:13:07+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-lente-contatto-rilascia-un-farmaco-la-congiuntivite-allergica/__pag_61_art_2_biblio/ 2022-04-14T12:14:37+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-naloxone-iniettabile-ad-alte-dosi-sovradosaggio-oppioidi/__pag_61_art_3_tab_1/ 2022-04-14T12:19:15+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-naloxone-iniettabile-ad-alte-dosi-sovradosaggio-oppioidi/__pag_61_art_3_biblio/ 2022-04-14T12:20:17+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-efgartigimod-alfa-la-miastenia-gravis/__pag_62_art_4_farmacologia/ 2022-04-14T12:24:35+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-efgartigimod-alfa-la-miastenia-gravis/__pag_62_art_4_punti_chiave/ 2022-04-14T12:25:33+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-efgartigimod-alfa-la-miastenia-gravis/__pag_63_art_4_biblio/ 2022-04-14T12:26:15+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-seconda-dose-richiamo-anziani-immunocompromessi/__pag_63_agg_covid_biblio/ 2022-04-14T12:30:15+00:00 https://www.med-life.it/number_articles/tml-n-8-2022-la-fda-limita-lutilizzo-del-sotrovimab/__pag_64_art_5_biblio/ 2022-04-14T12:35:39+00:00 https://www.med-life.it/number_articles/ad-n-2662021-osteonecrosi-della-mandibola-correlata-ai-farmaci-scoping-review/__pag_1088_tab_1/ 2022-05-09T09:40:17+00:00 https://www.med-life.it/number_articles/ad-n-2662021-osteonecrosi-della-mandibola-correlata-ai-farmaci-scoping-review/__pag_1090_biblio_1/ 2022-05-09T09:42:08+00:00 https://www.med-life.it/number_articles/ad-n-2662021-osteonecrosi-della-mandibola-correlata-ai-farmaci-scoping-review/__pag_1090_biblio_2/ 2022-05-09T09:42:42+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-farmaci-liperplasia-prostatica-benigna/__pag_66_art_1_punti_chiave/ 2022-05-09T10:01:18+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-farmaci-liperplasia-prostatica-benigna/__pag_67_art_1_punti_tab_1/ 2022-05-09T10:24:20+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-farmaci-liperplasia-prostatica-benigna/__pag_69_art_1_biblio_1/ 2022-05-09T10:26:29+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-farmaci-liperplasia-prostatica-benigna/__pag_69_art_1_biblio_2/ 2022-05-09T10:27:06+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-nuova-formulazione-acido-acetilsalicilico/__pag_70_art_2_punti_chiave/ 2022-05-09T12:26:17+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-nuova-formulazione-acido-acetilsalicilico/__pag_70_art_2_biblio/ 2022-05-09T12:27:18+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-nuova-formulazione-acido-acetilsalicilico/__pag_71_art_2_biblio_2/ 2022-05-09T12:27:48+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-impianto-oculare-ranibizumab-la-degenerazione-maculare-senile/__pag_71_art_3_punti_chiave/ 2022-05-09T12:53:45+00:00 https://www.med-life.it/number_articles/tml-n-9-2022-impianto-oculare-ranibizumab-la-degenerazione-maculare-senile/__pag_72_art_3_biblio/ 2022-05-09T12:55:48+00:00 https://www.med-life.it/numeri-saggio/tml-24-2021-1639-1640-15-dicembre_online/ 2022-05-20T15:31:20+00:00 https://www.med-life.it/numeri-saggio/tml-23-2021-1637-1638_online/ 2022-05-20T15:32:55+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-vaccino-anti-epatite-b-tre-antigeni/__pag_73_art_1_tab_1/ 2022-05-22T13:47:56+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-vaccino-anti-epatite-b-tre-antigeni/__pag_74_art_1_tab_2/ 2022-05-22T13:48:28+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-vaccino-anti-epatite-b-tre-antigeni/__pag_74_art_1_tab_3/ 2022-05-22T13:51:17+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-vaccino-anti-epatite-b-tre-antigeni/__pag_75_art_1_punti_chiave/ 2022-05-22T13:52:13+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-vaccino-anti-epatite-b-tre-antigeni/__pag_75_art_1_biblio_1/ 2022-05-22T13:53:43+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-vaccino-anti-epatite-b-tre-antigeni/__pag_75_art_1_biblio_2/ 2022-05-22T13:54:12+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-crema-base-tretinoina-benzoilperossido-lacne/__pag_75_art_2_punti_chiave/ 2022-05-22T14:02:06+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-crema-base-tretinoina-benzoilperossido-lacne/__pag_76_art_2_tab_1/ 2022-05-22T14:02:45+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-crema-base-tretinoina-benzoilperossido-lacne/__pag_76_art_2_tab_2/ 2022-05-22T14:04:52+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-crema-base-tretinoina-benzoilperossido-lacne/__pag_76_art_2_biblio/ 2022-05-22T14:05:55+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-budesonide-rilascio-ritardato-la-nefropatia-primaria-immunoglobulina/__pag_76_art_3_farmacologia/ 2022-05-22T14:10:13+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-budesonide-rilascio-ritardato-la-nefropatia-primaria-immunoglobulina/__pag_77_art_3_punti_chiave/ 2022-05-22T14:12:05+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-budesonide-rilascio-ritardato-la-nefropatia-primaria-immunoglobulina/__pag_77_art_3_biblio/ 2022-05-22T14:13:18+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-alcaftadina-banco-la-congiuntivite-allergica/__pag_78_in_breve_biblio/ 2022-05-22T14:19:12+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-alcaftadina-banco-la-congiuntivite-allergica/__pag_78_in_breve_1_tab_1/ 2022-05-22T14:20:06+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-semaglutide-dose-piu-alta-diabete-tipo-2/__pag_79_in_breve_2_tab_1/ 2022-05-22T14:27:08+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-semaglutide-dose-piu-alta-diabete-tipo-2/__pag_79_in_breve_2_biblio/ 2022-05-22T14:28:12+00:00 https://www.med-life.it/number_articles/tml-n-10-2022-dexlansoprazolo-la-gerd/__pag_80_addendum_tab_1/ 2022-05-22T14:38:55+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_81_sommario/ 2022-05-30T08:54:23+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_82_tab_1/ 2022-05-30T08:55:05+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_84_tab_2/ 2022-05-30T10:14:24+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_85_tab_3/ 2022-05-30T11:54:16+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_85_tab_4/ 2022-05-30T12:02:56+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_86_tab_4_segue/ 2022-05-30T12:03:49+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_86_tab_5/ 2022-05-30T12:04:46+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_87_tab_6/ 2022-05-30T12:07:07+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_88_biblio_1/ 2022-05-30T12:08:18+00:00 https://www.med-life.it/number_articles/tml-n-11-2022-farmaci-dispositivi-la-gestione-del-peso/__pag_88_biblio_2/ 2022-05-30T12:08:45+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-mavacamten-la-cardiomiopatia-ipertrofica-ostruttiva/__pag_90_art_1_punti_chiave/ 2022-06-13T12:39:18+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-mavacamten-la-cardiomiopatia-ipertrofica-ostruttiva/__pag_90_art_1_farmacologia/ 2022-06-13T12:40:02+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-mavacamten-la-cardiomiopatia-ipertrofica-ostruttiva/__pag_91_art_1_tab_1/ 2022-06-13T12:41:28+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-mavacamten-la-cardiomiopatia-ipertrofica-ostruttiva/__pag_91_art_1_biblio/ 2022-06-13T12:42:55+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-tenapanor-la-sindrome-dellintestino-irritabile-stipsi/__pag_92_art_2_farmacologia/ 2022-06-13T12:50:15+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-tenapanor-la-sindrome-dellintestino-irritabile-stipsi/__pag_92_art_2_tab_1/ 2022-06-13T12:50:58+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-tenapanor-la-sindrome-dellintestino-irritabile-stipsi/__pag_93_art_2_tab_2/ 2022-06-13T12:51:56+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-tenapanor-la-sindrome-dellintestino-irritabile-stipsi/__pag_94_art_2_punti_chiave/ 2022-06-13T12:52:59+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-tenapanor-la-sindrome-dellintestino-irritabile-stipsi/__pag_94_art_2_biblio_1/ 2022-06-13T12:54:40+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-tenapanor-la-sindrome-dellintestino-irritabile-stipsi/__pag_94_art_2_biblio_2/ 2022-06-13T12:55:31+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-dose-richiamo-del-vaccino-pfizer-bambini-eta-compresa-5-11-anni/__pag_95_art_agg_covid_biblio_1/ 2022-06-13T13:02:03+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-la-fda-limita-lautorizzazione-allimmissione-commercio-del-vaccino-johnson-johnson/__pag_95_fda_biblio_1/ 2022-06-13T13:06:13+00:00 https://www.med-life.it/number_articles/tml-n-12-2022-nih-sconsiglia-lutilizzo-dellivermectina/__pag_96_nih_biblio_1/ 2022-06-13T13:10:23+00:00 https://www.med-life.it/number_articles/tml-n-13-2022-farmaci-le-infezioni-sessualmente-trasmesse/__pag_98_tab_1/ 2022-06-24T08:42:28+00:00 https://www.med-life.it/number_articles/tml-n-13-2022-farmaci-le-infezioni-sessualmente-trasmesse/__pag_99_tab_1_segue/ 2022-06-24T08:42:59+00:00 https://www.med-life.it/number_articles/tml-n-13-2022-farmaci-le-infezioni-sessualmente-trasmesse/__pag_100_tab_1_segue/ 2022-06-24T08:43:31+00:00 https://www.med-life.it/number_articles/tml-n-13-2022-farmaci-le-infezioni-sessualmente-trasmesse/__pag_103_biblio_1/ 2022-06-24T12:07:10+00:00 https://www.med-life.it/number_articles/tml-n-13-2022-farmaci-le-infezioni-sessualmente-trasmesse/__pag_104_biblio_2/ 2022-06-24T12:07:47+00:00 https://www.med-life.it/number_articles/tml-n-13-2022-farmaci-le-infezioni-sessualmente-trasmesse/__pag_104_biblio_3/ 2022-06-24T12:08:13+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-tirzepatide-diabete-tipo-2/__pag_105_art_1_farmacologia/ 2022-07-09T13:08:49+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-tirzepatide-diabete-tipo-2/__pag_106_art_1_punti_chiave/ 2022-07-09T13:10:34+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-tirzepatide-diabete-tipo-2/__pag_106_art_1_tab_1-2/ 2022-07-09T13:11:59+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-tirzepatide-diabete-tipo-2/__pag_107_art_1_biblio-2/ 2022-07-09T13:13:31+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-daridorexant-linsonnia/__pag_107_art_2_punti_chiave/ 2022-07-09T13:20:48+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-daridorexant-linsonnia/__pag_108_art_2_farmacologia/ 2022-07-09T13:21:27+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-daridorexant-linsonnia/__pag_108_art_2_tab_1/ 2022-07-09T13:23:03+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-daridorexant-linsonnia/__pag_109_art_2_tab_2/ 2022-07-09T13:24:16+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-daridorexant-linsonnia/__pag_110_art_2_biblio/ 2022-07-09T13:25:43+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-daridorexant-linsonnia/__pag_110_art_2_biblio_2/ 2022-07-09T13:26:18+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-vaccini-pfizerbiontech-moderna-autorizzati-bambini-eta-%e2%89%a5-6-mesi/__pag_111_art_3_tab_1/ 2022-07-09T13:30:36+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-vaccini-pfizerbiontech-moderna-autorizzati-bambini-eta-%e2%89%a5-6-mesi/__pag_112_art_3_biblio_1/ 2022-07-09T13:31:55+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-vaccini-pfizerbiontech-moderna-autorizzati-bambini-eta-%e2%89%a5-6-mesi/__pag_112_art_3_biblio_2/ 2022-07-09T13:32:19+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-reazioni-ipersensibilita-tixagevimabcilgavimab/__pag_112_art_4_biblio_1/ 2022-07-09T13:36:04+00:00 https://www.med-life.it/number_articles/tml-n-14-2022-vaccini-pfizerbiontech-moderna-autorizzati-bambini-eta-%e2%89%a5-6-mesi/__pag_112_art_3_tab_2/ 2022-07-09T13:38:56+00:00 https://www.med-life.it/number_articles/ad-n-2672021-neuropatia-ottica-indotta-farmaci/__pag_1092_tab_1/ 2022-07-29T08:39:16+00:00 https://www.med-life.it/number_articles/ad-n-2672021-neuropatia-ottica-indotta-farmaci/__pag_1093_figura_1/ 2022-07-29T08:41:36+00:00